Priorities for reducing adult smoking: Best ... - David Hammond
Priorities for reducing adult smoking: Best ... - David Hammond
Priorities for reducing adult smoking: Best ... - David Hammond
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Priorities</strong> <strong>for</strong> Reducing Adult Smoking<br />
BEST PRACTICE TO REACH 12% BY 2011<br />
Prepared <strong>for</strong>:<br />
Health Canada &<br />
The Canadian Tobacco Control Research Initiative<br />
<strong>David</strong> <strong>Hammond</strong><br />
Jessica Reid<br />
March 2009<br />
i
TABLE OF CONTENTS<br />
Executive Summary ........................................................................................... ii<br />
Trends and Patterns Among Adult Smokers .................................................. 1<br />
Current Practice: What We Know Works ....................................................... 16<br />
<strong>Priorities</strong> <strong>for</strong> Action: Specific Interventions .................................................. 25<br />
<strong>Priorities</strong> <strong>for</strong> Action: Systems and Tools ...................................................... 30<br />
<strong>Priorities</strong> <strong>for</strong> Action: Research and Evidence ............................................... 33<br />
Summary .......................................................................................................... 36<br />
Additional In<strong>for</strong>mation Sources ..................................................................... 37<br />
Appendix A: Stakeholder Feedback – Specific Interventions ..................... 38<br />
Appendix B: Stakeholder Feedback – Systems & Tools .............................. 46<br />
Appendix C: Stakeholder Feedback – Research & Evidence ...................... 49<br />
References ....................................................................................................... 54<br />
i
EXECUTIVE SUMMARY<br />
Despite impressive declines in the prevalence of <strong>smoking</strong> over the past four decades,<br />
approximately 3.9 million Canadians over the age of 25 continue to smoke. As a consequence,<br />
interventions to reduce tobacco use remain among the most important and cost-effective public<br />
health measures.<br />
This report reviews best practices and priorities <strong>for</strong> <strong>reducing</strong> <strong>smoking</strong> prevalence among <strong>adult</strong>s.<br />
Recommendations are based upon feedback from 30 key stakeholders from the tobacco control<br />
community in Canada, representing different sectors and 7 provinces. Recommendations <strong>for</strong><br />
programs and policies were identified in each of the following areas: specific interventions,<br />
priorities <strong>for</strong> collecting research and evidence, and priorities <strong>for</strong> developing systems and tools.<br />
The primary theme of responses from stakeholders was that Canadian smokers are not receiving<br />
adequate services and support to quit <strong>smoking</strong>, and that Canada risks falling further behind in<br />
terms of regulations to reduce tobacco use. <strong>Priorities</strong> <strong>for</strong> action with potential <strong>for</strong> immediate<br />
impact include:<br />
<strong>Priorities</strong> <strong>for</strong> short-term reductions in prevalence:<br />
Curb contraband tobacco and en<strong>for</strong>ce price and taxation measures<br />
Improve access and use of existing cessation services<br />
Renew commitment to comprehensive media campaigns<br />
<strong>Priorities</strong> <strong>for</strong> longer-term reductions in prevalence:<br />
Expand and coordinate cessation services<br />
En<strong>for</strong>ce existing regulations, particularly with respect to contraband sales<br />
of cigarettes<br />
Develop and implement the next generation of policies: more<br />
comprehensive marketing bans, greater sales/access restrictions,<br />
stronger taxation measures, plain packaging, product regulation, and<br />
smoke-free areas<br />
Enhance partnerships with health professionals<br />
Develop new and ―alternative‖ cessation interventions<br />
Tailor cessation services to reach high-burden special populations<br />
Link policies, services and programs to a greater extent<br />
ii
TRENDS AND PATTERNS AMONG ADULT SMOKERS<br />
Decrease in prevalence among <strong>adult</strong> smokers has slowed.<br />
o Current <strong>smoking</strong> prevalence in Canada among <strong>adult</strong>s over 25 years of age is 17%.<br />
o Approximately 3.9 million Canadians over the age of 25 currently smoke—80% of all<br />
smokers in Canada are over 25.<br />
o The decline in prevalence has slowed or even stopped.<br />
o Overall <strong>smoking</strong> prevalence among <strong>adult</strong>s over 25 declined slowly between 1999 and<br />
2005 be<strong>for</strong>e reaching a plateau at 18-19% in the past few years.<br />
Smoking prevalence* (%), Canada, <strong>adult</strong>s 25+, CTUMS 1999-2008 1,2<br />
*Daily and nondaily <strong>smoking</strong><br />
** First half of 2008 (Feb-June) only<br />
1
There are substantial differences in <strong>adult</strong> prevalence across provinces.<br />
o Between 1999 and 2007, <strong>smoking</strong> prevalence among <strong>adult</strong>s over 25 declined in all<br />
provinces, be<strong>for</strong>e reaching a plateau in recent years.<br />
o Quebec has experienced the greatest decrease during this time (from 29 to 21%).<br />
o British Columbia has consistently had the lowest <strong>smoking</strong> prevalence.<br />
Smoking prevalence (daily & non-daily), by province, <strong>adult</strong>s 25+, CTUMS 2008* 2<br />
* First half of 2008 (Feb-June) only<br />
Smoking prevalence* (%), by province, <strong>adult</strong>s 25+, CTUMS 1999-2007 1<br />
1999 2000 2001 2002 2003 2004 2005 2006 2007<br />
CANADA 24 24 21 20 20 19 18 18 19<br />
Newfoundland 27 26 24 23 22 21 20 21 21<br />
PEI 24 25 25 22 20 21 19 19 18<br />
Nova Scotia 28 30 24 25 21 19 21 21 20<br />
New Brunswick 25 25 24 20 24 24 21 22 21<br />
Quebec 29 27 23 24 23 21 21 19 21<br />
Ontario 22 22 19 19 19 18 16 16 18<br />
Manitoba 22 25 24 20 20 20 21 19 19<br />
Saskatchewan 24 28 24 19 22 21 20 23 23<br />
Alberta 24 22 24 22 19 20 20 21 20<br />
British Columbia 19 19 16 16 16 14 14 16 15<br />
2
Smoking prevalence, %<br />
Number of smokers in Canadian provinces, by sex, 2005 4<br />
More males smoke than females, but the gap is narrowing.<br />
o 15.5% of females (1.8 million) and 19% of males (2.1 million) over 25 are current smokers.<br />
o In the most recent years, <strong>smoking</strong> prevalence appears to have continued to slowly decline<br />
among males, but increased slightly among females, narrowing the gender gap.<br />
30<br />
25<br />
Smoking prevalence (%), by sex, Canada, <strong>adult</strong>s 25+, CTUMS 1999-2007 1<br />
Males<br />
Females<br />
20<br />
15<br />
10<br />
5<br />
0<br />
1999 2000 2001 2002 2003 2004 2005 2006 2007<br />
Survey year<br />
3
Smoking prevalence is highest in 25-44 age group, and then declines.<br />
o Prevalence appears to decrease with age in all survey years.<br />
o Within age groups, <strong>smoking</strong> prevalence was higher among males in most years, although<br />
the gap between males and females <strong>for</strong> smokers over 65 appears to have closed in recent<br />
years.<br />
o Between 2006 and 2007, while <strong>smoking</strong> continued to decline <strong>for</strong> older age groups,<br />
prevalence appeared to increase <strong>for</strong> smokers aged 25-44.<br />
Smoking prevalence*, by age group and sex, <strong>adult</strong>s 25+, CTUMS 1999-2007 1<br />
‗*Daily and nondaily <strong>smoking</strong><br />
4
% Current Smokers<br />
Lower SES Canadians are more likely to smoke, but prevalence has<br />
declined at similar rates across all SES levels.<br />
o Smoking prevalence declined in all educational groups between 1999 and 2006.<br />
o Persistent educational differences were observed: <strong>smoking</strong> prevalence was lowest among<br />
university graduates in all years.<br />
Smoking Prevalence by Education Level, 1999-2006<br />
Smoking prevalence among Canadian <strong>adult</strong>s (25+), by education level, 1999-2006 3<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
1999 2000 2001 2002 2003 2004 2005 2006<br />
Year<br />
There are more middle/high income than low income smokers in Canada.<br />
Number of smokers in Canada, by family income and age group, 2005 4<br />
Rates of non-daily <strong>smoking</strong> have remained stable over time.<br />
o Non-daily <strong>smoking</strong> is far more common among 25-34-year olds (approximately 8% in the<br />
first half of 2008) vs. older <strong>adult</strong>s (approximately 3% or less).<br />
o Males have higher non-daily <strong>smoking</strong> rates than females within each age group.<br />
Daily and non-daily <strong>smoking</strong> prevalence (%), by sex, <strong>adult</strong>s 25+, CTUMS 1999-2007 1<br />
6
Daily and non-daily <strong>smoking</strong> prevalence (%), by sex, <strong>adult</strong>s 25+, CTUMS 1999-2007 1<br />
Focus on Non-daily Smokers<br />
Smoking patterns:<br />
Smoke an average of 2.8 days over the past week and 4.2 cigarettes per day<br />
Evenings and weekends (Fri/Sat) most common time to smoke<br />
Buy all or most of their cigarettes and fairly regularly smoke less than a whole cigarette<br />
Triggers include: socializing, stress and strong emotion, meals, alcohol, coffee, certain people<br />
Smoking history:<br />
Average age when they started to smoke regularly: 20 years<br />
Three quarters reported having smoked daily at one point, most within the past 5 years<br />
Opinions and attitudes:<br />
Most consider themselves smokers; those who don‘t report greater control or reduced CPD<br />
More than half think they will be <strong>smoking</strong> less than 12 months from now<br />
More perceive <strong>smoking</strong> as a habit rather than an addiction, except smokers aged 45-54 years<br />
Many concerned about health and report having cut back, particularly <strong>for</strong>mer daily smokers<br />
Most perceive a risk from <strong>smoking</strong>, but less than daily <strong>smoking</strong><br />
Quitting:<br />
80% have tried to quit (majority stated one or more times in past year)<br />
6 in 10 are seriously thinking of quitting in the next 6 months; 9 in 10 are confident they can quit<br />
Source: Health Canada. What Works on Quitting: Why Smokers Smoke. [presentation at TCD Strategic Planning Session]. 2008.<br />
7
Consumption levels among daily smokers continue to decline.<br />
o Over the past two decades, average cigarette consumption among daily smokers has<br />
dropped 27%, from 20.6 cigarettes per day (CPD) in 1985 to 15.0 in the first half of 2008.<br />
o There are significant differences in CPD between provinces: e.g., smokers over 45 in<br />
Newfoundland reported 14.1 CPD, compared to 18.4 CPD in New Brunswick.<br />
o Males have higher daily CPD than females within all age groups except 35-44 years.<br />
o Among males, CPD increases with age and is highest among smokers over 55.<br />
o Among females, the 35-44 age group has the highest daily consumption.<br />
o University graduates smoked ~3 fewer CPD than those with the lowest levels of education.<br />
o Time-to-first cigarette, a common measure of dependence, is similar across age groups<br />
among <strong>adult</strong> smokers, and only marginally greater <strong>for</strong> females than males.<br />
Average cigarettes smoked per day (daily smokers), by sex, <strong>adult</strong>s 25+, CTUMS 1999-2008 1,2<br />
*First half of 2008 (Feb-June) only<br />
Average cigarettes smoked per day (daily smokers), by age and sex, <strong>adult</strong>s 25+, CTUMS 2008* 2<br />
*First half of 2008 (Feb-June) only<br />
8
What is a ‘Hardcore’ Smoker?<br />
Health Canada has defined ―hardcore‖ smokers as: older than 25 years, smoked <strong>for</strong> at least five years,<br />
smoke 15 or more cigarettes per day, no quit attempts in past 12 months, and no intent to quit in the next<br />
6 months. Ten percent of <strong>adult</strong> smokers meet this criteria and have been characterized as follows:<br />
Older (mean age: 49 years) than both occasional smokers (35 years) and daily smokers (39 years)<br />
Started <strong>smoking</strong> daily at a slightly younger age (17.2 years vs. 17.9 years <strong>for</strong> daily smokers)<br />
More likely to have first cigarette within 5 minutes of waking<br />
Smoking patterns:<br />
Smoke wherever and whenever they can<br />
Home and car are two places they feel com<strong>for</strong>table <strong>smoking</strong><br />
Resent <strong>smoking</strong> bans - feel marginalized in society<br />
Opinions and attitudes:<br />
Justify their <strong>smoking</strong> behaviour<br />
Main barrier to quitting is fear of failure<br />
Aware of health risks - no lack of knowledge<br />
Rationalize and minimize the risks<br />
Less receptive to health warnings: they use personal experience rather than evidence<br />
Quitting:<br />
• By definition, hardcore smokers are not planning to quit in the next six months<br />
• What do they need to hear or see be<strong>for</strong>e they would be encouraged to try to quit?<br />
o Hard pressed to find anything anyone could do; they enjoy <strong>smoking</strong> and don‘t want to give it up<br />
o If the government was serious about wanting smokers to quit they would pay the cost of quitting<br />
Source: Health Canada. What Works on Quitting: Why Smokers Smoke. [presentation at TCD Strategic Planning Session]. 2008.<br />
The proportion of <strong>adult</strong> smokers who intend to quit is increasing.<br />
o The proportion of smokers who intend to quit <strong>smoking</strong> has increased from around half in<br />
1999 to nearly two thirds in the first half of 2008; only 25% of smokers report ―no intention<br />
to quit.‖<br />
o Age and gender differences in intention to quit were modest (see next page).<br />
% who intend to quit in the next 6 months, by age, CTUMS 1999-2008 1,2<br />
*First half of 2008 (Feb-June) only<br />
9
% who intend to quit in the next 6 months, by sex, <strong>adult</strong>s 25+, CTUMS 1999-2008 1,2<br />
* First half of 2008 (Feb-June) only<br />
Almost half of <strong>adult</strong> smokers have tried to quit in the past year.<br />
o Younger smokers are more likely to attempt to quit: 60% of smokers aged 25-34 attempted to<br />
quit in past year compared to 45% of smokers 35 years and older.<br />
o Gender differences are modest.<br />
o Lower SES smokers appear to be equally likely to try to quit <strong>smoking</strong>; however, recent UK<br />
data suggests they may be less successful when doing so. 5<br />
o Inconsistencies in question coverage make comparisons over time difficult/inappropriate.<br />
10
% who attempted to quit in the past year* <strong>adult</strong>s 25+, CTUMS 1999-2008 1,2<br />
*Note: Question coverage is inconsistent: 2000-2002 surveys included current smokers [probably also 1999 –<br />
unconfirmed]; 2003 survey included only smokers who had tried to quit in the past 2 years; 2004-2007 included current<br />
smokers and <strong>for</strong>mer smokers who had quit in past 12 months [probably also 2008 – unconfirmed]<br />
** First half of 2008 (Feb-June) only<br />
11
TV and cigarette packs are the most common sources of cessation<br />
in<strong>for</strong>mation among <strong>adult</strong> smokers.<br />
o Television was the most common source of in<strong>for</strong>mation on the dangers of <strong>smoking</strong> and<br />
in<strong>for</strong>mation on quitting. 6<br />
o Just under half of smokers had received advice from a healthcare professional. 6<br />
o Lower income and lower education level appear to be associated with slightly decreased<br />
likelihood of noticing/receiving anti-<strong>smoking</strong> messages. 6<br />
o There were no significant differences across income groups in receiving anti<strong>smoking</strong>/cessation<br />
in<strong>for</strong>mation from health care sources. 6<br />
Sources of anti-<strong>smoking</strong> in<strong>for</strong>mation <strong>for</strong> <strong>adult</strong> daily smokers, ITC 4-Country Survey, 2006/07 (n=1622) 6<br />
12
Half of <strong>adult</strong> smokers received some <strong>for</strong>m of cessation assistance in<br />
the past year.<br />
o The majority of Canadian smokers surveyed in the 2006-07 wave of the ITC Four<br />
Country Survey had used some <strong>for</strong>m of cessation assistance since they were last<br />
surveyed (in the past year). 7<br />
o Almost half of Canadian smokers surveyed in the ITC study had received assistance<br />
from a health professional through advice, a pamphlet, a referral, or a prescription; when<br />
only those who had visited a health professional were included, this proportion increased<br />
to almost two-thirds. 7<br />
o Recent research shows that Canadian smokers are receptive to quit advice<br />
from physicians, but less likely to ask other health professionals. Few smokers<br />
received advice from pharmacists and dentists. 8<br />
o Few of the smokers surveyed in the ITC study had used other <strong>for</strong>ms of assistance, such<br />
as telephone helplines, the internet, and local services. 7<br />
o The most recent data suggests that approximately 17% of daily smokers in<br />
Canada report using nicotine replacement therapy (NRT) in the past year. 9<br />
o<br />
Among NRT users, the patch is approximately twice as popular as nicotine<br />
gum, with very low rates of use <strong>for</strong> the nicotine inhaler and lozenge. 9<br />
Use of various <strong>for</strong>ms of cessation assistance in the past year ITC 2006/07, Canada (n=2022) 7<br />
13
Use of cessation assistance in the past year (or since last surveyed), by income group, ITC 2006/07,<br />
Canada (n=2022) 7<br />
Most smokers pay full price <strong>for</strong> stop-<strong>smoking</strong> medications.<br />
o Among NRT users surveyed in the 2006/07 wave of the ITC:<br />
o Six in ten had obtained their NRT over-the-counter. 7<br />
o 73% paid full price <strong>for</strong> NRT at last use; less than 10% received NRT ―free.‖ 7<br />
o A third received NRT by prescription rather than ―over the counter.‖ 7<br />
o Approximately 6 out of 10 smokers would be interested in NRT if it were offered <strong>for</strong> free. 10<br />
Many Canadians hold false beliefs about nicotine replacement<br />
therapy.<br />
o Approximately one third of smokers report that stop-<strong>smoking</strong><br />
medications might harm their health. 11<br />
o Approximately one third of smokers believe nicotine in<br />
cigarettes causes ―most of the cancers.‖ 11<br />
o Many smokers use NRT <strong>for</strong> an insufficient amount of time. 11<br />
Smokers want more in<strong>for</strong>mation about quitting.<br />
o Approximately 9 out of 10 smokers report a desire <strong>for</strong> more in<strong>for</strong>mation on quitting. 12<br />
o Knowledge of stop-<strong>smoking</strong> medications and other types of <strong>for</strong>mal assistance may<br />
increase likelihood of trying to quit and adoption of assistance when doing so.<br />
14
SUMMARY OF PATTERNS AND TRENDS<br />
The prevalence of <strong>smoking</strong> has steadily decreased <strong>for</strong> approximately 4 decades;<br />
however, the rate of decline may have slowed in recent years.<br />
The evidence does not support a ―hardening‖ of Canadian smokers; rather, intentions<br />
to quit and quit attempts have increased among <strong>adult</strong>s in recent years.<br />
Socioeconomic inequalities persist; however, prevalence has declined among all SES<br />
groups at a similar rate over the past 10 years.<br />
There is a serious lack of in<strong>for</strong>mation on patterns of quitting among Canadian <strong>adult</strong>s,<br />
as well as the effectiveness of different cessation services and interventions.<br />
Adult smokers express a strong desire <strong>for</strong> additional cessation in<strong>for</strong>mation and<br />
support.<br />
15
CURRENT PRACTICE: WHAT WE KNOW WORKS<br />
Tobacco control policies work.<br />
Tobacco control regulations and population-level policies are primarily responsible <strong>for</strong> the<br />
significant declines in <strong>smoking</strong> prevalence observed over the past 40 years. Measures to<br />
increase the price of tobacco products, comprehensive restrictions on<br />
tobacco industry marketing, comprehensive smoke-free policies, mass<br />
media campaigns, and large pictorial health warnings on tobacco<br />
packaging are among the most effective policy measures to reduce<br />
tobacco use among <strong>adult</strong>s. Although Canada has set international<br />
precedents in several of these policy domains in the past, it has<br />
recently fallen behind in a number of policy areas and has yet to fulfill<br />
its obligations under the WHO Framework Convention on Tobacco<br />
Control in several key areas. In order to achieve further declines in<br />
<strong>smoking</strong> prevalence in the medium and longer-term, Canada must<br />
develop and implement the next generation of tobacco control<br />
policies, several of which are discussed in the next section under<br />
<strong>Priorities</strong> <strong>for</strong> Action.<br />
Increasing accessibility and use of cessation services<br />
A range of cessation methods increase the likelihood of long-term abstinence from <strong>smoking</strong>.<br />
Although an increasing proportion of Canadians report using some <strong>for</strong>m of cessation<br />
assistance when attempting to quit, most smokers still try to quit without any type of <strong>for</strong>mal<br />
help. Increasing the use of the cessation services reviewed below is likely to increase<br />
population-level cessation rates in the short to medium term.<br />
Self-help materials<br />
Standard self-help materials can increase quit rates compared to no intervention, but the<br />
effect is typically modest. 13 There is evidence that materials that are tailored <strong>for</strong> individual<br />
smokers are more effective than untailored materials, although the absolute effect size is<br />
small. There is a lack of evidence that self-help materials provide additional benefit when<br />
used alongside other interventions such as advice from a healthcare professional, or<br />
nicotine replacement therapy.<br />
Contests and incentives<br />
―Quit & Win‖ contests and providing financial incentives <strong>for</strong> <strong>smoking</strong> cessation are an<br />
increasingly common community-based intervention to reduce tobacco use. Although<br />
contests and incentives do not appear to increase the likelihood of long-term abstinence <strong>for</strong><br />
a given quit attempt, they have the potential to reduce prevalence by stimulating a greater<br />
number of quit attempts in the population. 14<br />
Mass media<br />
Mass media interventions involve communication through television, radio, newspapers,<br />
billboards, posters, leaflets or booklets, with the intention of encouraging smokers to quit,<br />
16
and of maintaining abstinence in non-smokers. Media campaigns contribute to a reduction in<br />
<strong>smoking</strong> when used as part of a comprehensive set of interventions. 15 There is a growing<br />
evidence base on effective themes and executional styles to direct campaign strategies. 16<br />
Face-to-face counselling<br />
Individual face-to-face counselling (often with supplemental telephone support) can help<br />
smokers quit, but there is insufficient evidence regarding whether more intensive counselling<br />
is better. 17 Group counselling 18 is more effective <strong>for</strong> helping people to stop <strong>smoking</strong> than<br />
self-help materials without face-to-face instruction and group support. It is unclear whether<br />
groups are better than individual counselling or other advice, but they are more effective<br />
than no treatment. Not all smokers making a quit attempt want to attend group meetings, but<br />
<strong>for</strong> those who do, group counselling is likely to be helpful.<br />
Telephone counselling<br />
Counselling via telephone hotlines can be provided as part of a program or on its own, and<br />
can potentially reach large numbers of people. A review of trials found telephone counselling<br />
to be effective; multiple sessions are likely to be most helpful. 19<br />
Web-assisted interventions<br />
The internet can be an effective medium <strong>for</strong> providing <strong>smoking</strong> cessation counselling and<br />
providing self-help materials. Web-assisted interventions can be very cost-effective and<br />
seem to appeal to a reasonable number of Canadian smokers. 20,21<br />
Counselling & brief advice from health professionals<br />
Advice from doctors increases long-term abstinence from<br />
<strong>smoking</strong>. 22 Even brief advice increases the likelihood of<br />
abstinence one year later, while more intensive advice<br />
may result in slightly higher rates of quitting. Providing<br />
follow-up support after offering the advice may further<br />
increase quit rates. Advice and support from other health<br />
professionals, including dentists, 23 nurses, 24 and<br />
pharmacists, 25 can also increase abstinence rates,<br />
particularly when delivered in a hospital setting.<br />
Pharmacotherapy<br />
Seven ―first-line‖ medications reliably increase long-term <strong>smoking</strong> abstinence rates:<br />
bupropion SR, varenicline, and 5 nicotine-based medications: nicotine gum, inhaler,<br />
lozenge, nasal spray, and patch. 26,27,28 In addition, two ―second-line‖ medications increase<br />
the odds of quitting: clonidine and ortriptyline. Certain combinations of first-line medications<br />
have also been shown to be effective <strong>smoking</strong> cessation treatments, most notably long-term<br />
(>14 weeks) nicotine patch + other NRT (gum and spray), the nicotine patch + the nicotine<br />
inhaler, and the nicotine patch + bupropion SR.<br />
Workplace interventions<br />
Proven stop-<strong>smoking</strong> methods, like group therapy, individual counselling and nicotine<br />
replacement therapy, are equally effective when offered in the workplace. 29 The evidence is<br />
less clear <strong>for</strong> self-help methods. Social and environmental support, competitions and<br />
incentives, and comprehensive programs do not show a clear benefit in helping smokers to<br />
quit at work.<br />
17
CASE STUDY: Increasing use of cessation services in the UK<br />
Recent data suggest that only 4% of smokers make use of the UK‘s national stop <strong>smoking</strong> services.<br />
A consultation report provided the following recommendations:<br />
Increasing access and accessibility:<br />
Stop <strong>smoking</strong> services need to be available in a variety of settings, including: the workplace;<br />
community pharmacies; schools and colleges; and, community resources;<br />
Cessation in<strong>for</strong>mation and resources should be widely available and provided in different<br />
languages with internet-based resources;<br />
‗Smoke-free families‘ initiatives should be available through schools and Children‘s Centres;<br />
Outreach services should be made available through mobile units;<br />
Services should operate extended hours;<br />
A 24 hour helpline is needed; and,<br />
Stop <strong>smoking</strong> services should be open to smokers who have had an unsuccessful quit attempt as<br />
soon as they are ready to try again.<br />
Identifying and reaching smokers proactively:<br />
Hospitals should record the <strong>smoking</strong> status of all patients;<br />
Routine screening <strong>for</strong> tobacco use among pregnant women;<br />
Clinical staff, including midwives and oral health professionals, should be able to provide brief<br />
interventions and referral to stop <strong>smoking</strong> advice, and there should be training and protected time<br />
<strong>for</strong> this;<br />
Referral to stop <strong>smoking</strong> services should be part of the GP‘s Quality and Outcomes Framework;<br />
and,<br />
Proactive contact of previous service users who failed to quit.<br />
Vulnerable groups and hard to engage groups:<br />
Smoking cessation should be embedded as part of a wider drive to improve general health and<br />
well-being promotion in services working with the most marginalised groups, including drug<br />
treatment services;<br />
GPs should ask patients with severe mental illness to be registered <strong>for</strong> annual physical health<br />
checks, using this as an opportunity to offer cessation support;<br />
Tailored <strong>smoking</strong> cessation programs <strong>for</strong> people with mental health problems; and,<br />
Cessation services should be located in prisons, as this would create an opportunity to reach<br />
target groups, among them disadvantaged young males, who are otherwise hard to reach; and in<br />
deprived areas, where prevalence is high.<br />
Source: UK Department of Health. Consultation on the future of tobacco control: consultation report, 2008.<br />
Available online at: http://www.dh.gov.uk/en/Consultations/Responsestoconsultations/DH_091382.<br />
Comprehensive and integrated tobacco control programs work.<br />
Comprehensive tobacco control programs have consistently been demonstrated as the most<br />
effect approach to <strong>reducing</strong> prevalence. 30,31,32 The most dramatic declines in prevalence<br />
observed within jurisdictions are difficult to attribute to any one intervention or approach;<br />
rather, they reflect the combined effects of multiple programs and a comprehensive set of<br />
tobacco control regulations. 30,31<br />
18
Effective tobacco control programs not only have a comprehensive list of policies and<br />
programs, they also link and integrate these programs and policies to maximize their<br />
effectiveness. In Canada, different levels of government have largely failed to exploit the<br />
potential to link different types of mass media campaigns and to link these campaigns with<br />
effective cessation services. The case study below illustrates the potential benefit of<br />
developing stronger links across individual initiatives. Other possibilities include linking brief<br />
advice from health professionals—one of the most common and effective sources of<br />
cessation in<strong>for</strong>mation—with concrete cessation services beyond the health care setting.<br />
CASE STUDY: Linking policies and programs<br />
In 2006, Australia provided an effective example of linking three types of programs and policies: new<br />
health warnings on packages, telephone quitlines, and mass media campaigns. Providing telephone<br />
quitlines on packages has proven to be an excellent way of stimulating additional quit attempts and<br />
linking smokers making these quit attempts to an effective cessation service. Evidence from the<br />
Netherlands, UK, Brazil, and Australia all<br />
demonstrate that calls to quitline services jump significantly<br />
when these numbers are provided on packages.<br />
New South Wales, one of the Australian states, also featured<br />
images from the new health warnings in a mass media<br />
campaign, including television, print, and billboard ads.<br />
These advertisements helped to make the in<strong>for</strong>mation on<br />
health warnings more vivid and provided a compelling<br />
narrative to the pictures and text. Smokers who see these<br />
advertisements are likely to recall them each time they see<br />
the related images on the pack. An evaluation of this media<br />
campaign indicated that it was among the most effective<br />
mass media campaigns in the state.<br />
For more in<strong>for</strong>mation on this campaign, please visit:<br />
http://www.cancerinstitute.org.au/cancer_inst/campaigns/healthwarnings2006.html.<br />
Source: <strong>Hammond</strong> D. Tobacco labelling and packaging toolkit: A guide to FCTC Article 11. Available online at:<br />
www.tobaccolabels.org.<br />
Recruiting the services of health professionals works.<br />
Brief advice from health professionals is among the most common sources of cessation<br />
in<strong>for</strong>mation and support <strong>for</strong> Canadian smokers, and is extremely cost-effective. A series of<br />
clinical practice guidelines have been developed <strong>for</strong> a variety of health professionals;<br />
however, the potential role of health professionals in promoting <strong>smoking</strong> cessation among<br />
<strong>adult</strong>s has yet to be fully realized. In addition, cessation services have yet to be properly<br />
integrated with the primary care system, as described below.<br />
19
Comprehensive cessation services work….at a cost.<br />
A number of countries have recently invested in national <strong>smoking</strong> cessation services. 33<br />
Although there is no <strong>for</strong>mal definition of what constitutes a comprehensive cessation<br />
service, several common factors include: 1) a centralized, nationally coordinated structure,<br />
2) dedicated cessation ―clinics‖ with expanded access to behavioural and pharmacotherapy<br />
services, and 3) subsidies and expanded coverage <strong>for</strong> the costs of services, particularly <strong>for</strong><br />
disadvantaged groups. In several cases, such as the UK and South Korea, responsibility <strong>for</strong><br />
coordinating and funding cessation services falls within the primary health care system.<br />
Comprehensive cessation services are resource intensive, as illustrated by the examples<br />
below. Advocates of comprehensive services argue that cessation services are an extremely<br />
cost-effective investment relative to other health expenditures; however, the cost of creating<br />
such a system remains a barrier in many jurisdictions, particularly where cessation services<br />
must be developed outside of agencies responsible <strong>for</strong> primary health care.<br />
Do comprehensive cessation services help to significantly reduce <strong>smoking</strong> prevalence?<br />
There is strong evidence that the individual components in a cessation service are effective.<br />
There are also a number of evaluations of the impact of the national service implemented in<br />
the UK (see example below). For example, data from a cohort of smokers in the UK and in 3<br />
other countries (Canada, the US, and Australia) suggest that UK smokers are no more likely<br />
to intend or attempt to quit <strong>smoking</strong> than smokers in Canada, the US, and Australia;<br />
however, it appears that UK smokers making quit attempts are somewhat more likely to<br />
succeed and remain abstinent than smokers attempting to quit in Canada, the US and<br />
Australia. 7 Although this difference cannot necessarily be attributed to the national cessation<br />
service operated by the National Health Service in the UK, it does provide some intriguing<br />
cross-country comparisons using population-based data.<br />
CASE STUDY: Evaluation of comprehensive cessation services in the UK<br />
Approximately 10 years ago, the UK government developed a comprehensive national cessation<br />
service under the National Health Service. Smoking cessation services included behavioural and<br />
pharmaceutical interventions, such as brief advice and counselling, intensive support, and the<br />
administration and subsidization of nicotine replacement therapy (NRT) and bupropion.<br />
Comprehensive services, such as the one introduced by the NHS in the UK are expensive. For<br />
example, approximately 300 million dollars was invested over a 3-year period.<br />
An evaluation of the NHS cessation services concluded that: NHS intensive interventions are<br />
―reasonably‖ effective at increasing cessation rates in the long-term. The report also indicates:<br />
1. The content of the interventions may influence their effectiveness.<br />
‗Intermediate interventions‘ appear to be effective in facilitating <strong>smoking</strong> cessation. Group<br />
interventions may be more effective than those delivered one-on-one, although both types of<br />
intervention are essential <strong>for</strong> the continuation of the services.<br />
...continued on following page<br />
20
CASE STUDY: Evaluation of comprehensive cessation services in the UK<br />
2. The settings may have an effect.<br />
There is some indirect evidence that the setting may influence effectiveness, but this evidence is not<br />
conclusive. However, there is strong evidence that inpatient interventions in hospital settings are<br />
effective in facilitating <strong>smoking</strong> cessation<br />
3. External factors affect success rates.<br />
Factors such as target setting appear to have influenced the effectiveness of intensive <strong>smoking</strong><br />
cessation interventions.<br />
4. Sub-group & client characteristics are important.<br />
The characteristics of certain sub-groups also have an effect on the effectiveness of the NHS services.<br />
Age, sex, level of addiction and previous quit attempts are all correlated with quitting success. While<br />
females set more quit dates than males, they were less likely to succeed in quitting than males. Older<br />
smokers (both male and female) were also more likely to quit successfully than younger smokers.<br />
Also, several sub-populations face unique barriers in attempting to quit <strong>smoking</strong>. Pregnant women,<br />
smokers from ―blue collar‖ professions, and institutionalised populations all face substantial barriers<br />
that impede <strong>smoking</strong> cessation attempts.<br />
Source: Bell K, McCullough L, Greaves L, et al. NICE Rapid Review: The Effectiveness of National Health Service Intensive<br />
Treatments <strong>for</strong> Smoking Cessation in England, 2007.<br />
At present, Canada does not have anything approaching a comprehensive, national<br />
<strong>smoking</strong> cessation service. However, the province of Quebec has implemented the most<br />
comprehensive subsidization program <strong>for</strong> pharmacotherapies, as described below.<br />
CASE STUDY: Subsidizing stop-<strong>smoking</strong> medication in Quebec<br />
In September 2000, Quebec added coverage of three stop-<strong>smoking</strong> medications to its provincial<br />
medication insurance plan: bupropion, nicotine patch, and gum, followed by the nicotine lozenge.<br />
Between 2000 and 2004, coverage cost $55 million <strong>for</strong> approximately 306,000 individuals, or<br />
approximate $181/user.<br />
The subsidization plan has resulted in greater use of NRT.<br />
Overall, the plan is a cost-effective measure relative to other types of medication coverage.<br />
Strong majorities of health professionals support the plan.<br />
The only other province with special coverage <strong>for</strong> stop-<strong>smoking</strong> medications is PEI, where<br />
coverage is provided <strong>for</strong> participants in group and individual counselling, up to a maximum of<br />
$75/year. Manitoba has removed the PST on nicotine replacement therapy.<br />
Source: Institute National De Sante Publique du Quebec. Remboursement des aides pharmacologiques a l‘arret<br />
tabagique au Quebec. Phase II. 2007. Available online at: http://www.inspq.qc.ca/pdf/publications/707-PCAPFinal.pdf.<br />
A review of subsidization programs from other jurisdictions concluded that:<br />
“Increasing the level of health insurance coverage or <strong>reducing</strong> direct costs of <strong>smoking</strong><br />
cessation treatment may increase the number of smokers who quit successfully, as well<br />
as the number of quit attempts and the use of treatment. There is not enough evidence to<br />
show whether offering financial incentives to healthcare providers <strong>for</strong> identifying and<br />
treating smokers is effective in increasing the number of smokers who quit.”<br />
Source: Kaper J, Wagena EJ, Severens JL, Van Schayck CP. Healthcare financing systems <strong>for</strong> increasing the use of<br />
tobacco dependence treatment. Cochrane Database of Systematic Reviews 2005, Issue 1.<br />
21
Target audiences and special populations<br />
Population-based interventions that are targeted at the entire population are likely to have<br />
the greatest impact on prevalence rates. Interventions that have a relatively modest effect<br />
on individuals can have a significant impact on population-level trends if they have sufficient<br />
reach. As a result, tailoring interventions to specific target groups can limit their impact if it<br />
also limits the reach and audience of smokers.<br />
A recent review in the area of mass media campaigns also provides encouraging evidence<br />
that interventions do not need to target sub-groups to be highly effective. The review<br />
examined the effectiveness of targeting media at different age groups (e.g., youth vs. <strong>adult</strong>s)<br />
and different ethnicities, and concluded that campaigns that were effective with <strong>adult</strong>s were<br />
also those most likely to be effective with youth and other sub-groups. Another common<br />
approach is to tailor media campaigns based upon intentions to quit, such as creating<br />
separate messages <strong>for</strong> ―hardcore‖ smokers. However, the evidence suggests that smokers<br />
who are not interested in quitting respond to the same types of messages as those that are<br />
willing to quit: emotionally-engaging messages that also provide concrete in<strong>for</strong>mation and<br />
support <strong>for</strong> cessation. In other words, the evidence suggests only limited value in expending<br />
significant resources to create tailored media campaigns <strong>for</strong> different subgroups. 16 Not all<br />
interventions are similar, and there may be sound reasons <strong>for</strong> targeting sub-groups of<br />
smokers <strong>for</strong> some types of interventions. For example, nicotine replacement therapy has not<br />
been demonstrated to be very effective among individuals who smoke fewer than 10<br />
cigarettes per day. Nevertheless, unless there is a compelling reason to limit the target<br />
audience <strong>for</strong> a particular intervention, policies and programs should adopt a broad,<br />
population-based approach, particularly where resources are limited. Canadian trends in<br />
<strong>smoking</strong> prevalence and consumption also provide general support <strong>for</strong> this approach:<br />
prevalence and consumption have been declining at approximately the same rate <strong>for</strong><br />
different genders and socio-economic groups in Canada. Reviews from other countries also<br />
suggest population-based policies reduce, rather than exacerbate, inequalities. 34<br />
Nevertheless, there is a strong argument <strong>for</strong> targeting services at disadvantaged groups.<br />
There is also an increasing evidence base concerning effective strategies to do so. 35 Where<br />
targeting does take place, it should focus upon sub-groups that bear a significant proportion<br />
of the health burden from tobacco use. Three of these special populations (First Nations,<br />
persons with mental illness, and pregnant women) are described below.<br />
First Nations<br />
Prevalence of <strong>smoking</strong> among First Nations is estimated at more than 50%—approximately<br />
three times the levels of the general population—and does not appear to be declining at the<br />
same rate as other Canadians. 36,37 Alarming levels of <strong>smoking</strong> have also been observed<br />
among other Aboriginal populations, particularly among the Inuit,<br />
where prevalence estimates reach as high as 70%. 38 In addition to the<br />
high prevalence of <strong>smoking</strong>, there are a number of other compelling<br />
reasons <strong>for</strong> developing specific strategies <strong>for</strong> First Nations<br />
communities, including the prevalence of other addictive behaviours,<br />
traditional use of tobacco and other cultural factors, as well as the<br />
presence of tobacco manufacturing in some communities.<br />
22
Persons with mental illness<br />
Individuals with psychiatric illness have a much higher prevalence of <strong>smoking</strong>, as well as<br />
substantially higher levels of daily consumption. 39 Prevalence among the mentally ill is<br />
approximately double that of the general population, and may be as high as 90% among<br />
people diagnosed with schizophrenia. 40 A number of biological, psychological, and social<br />
factors may explain these high <strong>smoking</strong> rates, including the lack of <strong>smoking</strong> cessation<br />
treatment in mental health settings. The most effective interventions to help psychiatric<br />
patients stop <strong>smoking</strong> are similar to those that are effective in the general population;<br />
however, there are a number of special considerations <strong>for</strong> this sub-population, including<br />
factors such as demographics, diagnosis and concurrent medication use. 41 In addition, an<br />
over-emphasis on the ―self-medication hypothesis‖ to explain the high rates of tobacco use<br />
in psychiatric populations may result in inadequate attention to other potential explanations<br />
<strong>for</strong> this addictive behaviour among those with mental disorders.<br />
Pregnant women<br />
In 2002, over 200,000 Canadian women (~14%) smoked while pregnant. 42 Significant<br />
numbers of pregnant women are also exposed to second-hand smoke. Smoking during<br />
pregnancy is associated with several serious risks, including preterm delivery, spontaneous<br />
abortion, growth restriction, increased risk of sudden infant death syndrome (SIDS), as well<br />
as long-term behavioural and psychiatric disorders. 43 Interventions to reduce <strong>smoking</strong> during<br />
pregnancy also provide the opportunity to promote long-term abstinence, as well as to<br />
reduce post-natal exposure to second-hand smoke. Pregnant smokers and mothers with<br />
young children merit tailored interventions and more intensive ef<strong>for</strong>ts to overcome barriers. 44<br />
Is there an optimum setting to reach <strong>adult</strong>s?<br />
Health care settings<br />
Hospitals, pharmacies, long-term care, mental facilities, walk-in clinics and other health care<br />
settings are among the most effective settings in which to reach <strong>adult</strong> smokers. Health care<br />
professionals are already an important partner <strong>for</strong> <strong>smoking</strong> cessation interventions;<br />
however, these ef<strong>for</strong>ts need to be enhanced to accelerate reductions in prevalence. In<br />
particular, interventions should link health care professionals and health care consumers<br />
within these settings to effective cessation services outside of these settings. Telephone<br />
quitlines, web-assisted interventions, subsidized access to stop-<strong>smoking</strong> medications, and<br />
other <strong>for</strong>mal sources of support can be used supplement existing services and as a way to<br />
offer concrete support in addition to brief advice to quit.<br />
Media<br />
Comprehensive media campaigns are a critical component of any tobacco control program<br />
and are an important means of increasing quit attempts and encouraging the use of effective<br />
cessation methods. Cessation campaigns also help to generate public and political support<br />
<strong>for</strong> more comprehensive policies and programs. Canada has lagged far behind many other<br />
jurisdictions in this critical area and a renewed commitment to strong media campaigns is<br />
essential to reductions in <strong>smoking</strong> prevalence in both the near and longer term.<br />
23
Occupational settings<br />
Workplaces provide an opportunity to reach large numbers of smokers. Proven stop<strong>smoking</strong><br />
methods, like group therapy, individual counselling and nicotine replacement<br />
therapy, are equally effective when offered in the workplace. 45 Where resources are scarce,<br />
workplaces with higher proportions of smokers should be targeted. 46 Alternatively, some<br />
occupational settings have lower prevalence rates, but have very large numbers of<br />
employees; as a result, there may be larger absolute numbers of smokers in these settings.<br />
Retail settings<br />
Retail outlets are an excellent setting in which to target <strong>adult</strong> smokers. Most smokers<br />
continue to purchase their cigarettes from retail settings, primarily from convenience stores<br />
or small grocery stores.Retail outlets also have incredibly high reach among the general<br />
population, including children and youth. To date, the potential to use retail settings to<br />
promote <strong>smoking</strong> cessation and tobacco control has largely gone unexploited. Tobacco<br />
control agencies should explore whether paid media in retail outlets is a cost-effective<br />
medium. Retail settings could also be targeted through more comprehensive regulation. For<br />
example, at least one Australian state requires a telephone quitline to be prominently<br />
displayed in any retail outlet where tobacco is sold. The province of British Columbia also<br />
requires a sign to be displayed at the point of sale. The effectiveness of these interventions<br />
could be improved significantly by requiring a rotating series of messages and by providing<br />
concrete in<strong>for</strong>mation on quitting. These messages should also be linked with other media<br />
campaigns, including television advertisements, health warnings on tobacco packages, etc.<br />
Levels of government (federal, provincial, municipal)<br />
The fragmentation of services across different levels of government is perhaps the most<br />
significant barrier to a comprehensive cessation strategy in Canada. At present, there is a<br />
lack of coordination across jurisdictions, resulting in major gaps and inequalities in the types<br />
of services available to smokers. Of the three levels of government, Health Canada has the<br />
strongest mandate—and bears the greatest responsibility—<strong>for</strong> coordinating services on a<br />
national level. The example of telephone quitlines illustrates both the challenges and<br />
opportunities <strong>for</strong> developing services at a national level. Recently, the renewal of health<br />
warnings on cigarette packages provided an opportunity to print a telephone quitline number<br />
on all packages. However, not all provinces offered quitlines and those that did, used<br />
different telephone numbers. Health Canada has been working with the various<br />
stakeholders to ensure that a single number printed on all packages sold in Canada will<br />
allow smokers to contact a helpline in every province.<br />
Centralization of services across different levels of government is also a cost-effective<br />
option. Major interventions, such as web-based cessation interventions, materials <strong>for</strong><br />
training health professionals, etc., need not be duplicated at various levels of administration.<br />
Not all types of interventions—such as workplace interventions and the implementation of<br />
various policies—are as easily centralized or standardized as telephone quitlines.<br />
Nevertheless, Health Canada must take the lead in developing a coordinated level of<br />
service across jurisdictions. Ultimately, it makes no difference to the smoker whether a<br />
particular service is provided by a local, provincial, or federal program; what matters is that<br />
these services are available and of comparable quality across the country.<br />
24
PRIORITITES FOR ACTION: SPECIFIC INTERVENTIONS<br />
In order to identify priorities <strong>for</strong> action, approximately 50 key tobacco control stakeholders<br />
were contacted via email and invited to submit recommendations and proposals. A total of<br />
30 stakeholders replied. These stakeholders represented 7 different provinces and various<br />
sectors, including the research/academic community (n=13) and the public sector, including<br />
several program providers (n=5), as well as non-governmental organizations (n=12).<br />
The purpose of this exercise was not to conduct an exhaustive consultation with a<br />
representative sample of stakeholders, but to solicit a range of ideas and perspectives to<br />
help frame a national discussion on strategies to reduce <strong>adult</strong> prevalence. The following<br />
sections describe common themes, as well as illustrative quotes within each area.<br />
More comprehensive policy measures and regulations (20 comments)<br />
Price measures: taxation and contraband (28 comments)<br />
There was almost unanimous agreement among<br />
stakeholders that measures to increase the price of<br />
cigarettes and address the threat from contraband tobacco<br />
are the most important strategies <strong>for</strong> <strong>reducing</strong> <strong>adult</strong> <strong>smoking</strong><br />
both in the immediate future and in the long term.<br />
“Controlling the illicit market and raising prices. In the short term, nothing else will have<br />
much effect.”<br />
“ Ensure continued tobacco tax increases on a regular basis equivalent to or<br />
exceeding inflation... Increase taxes on roll-your-own (loose/RYO) tobacco<br />
proportionally more than manufactured cigarettes to equalize prices. Taxes on loose<br />
or RYO tobacco should be increased in proportionally greater amounts than<br />
manufactured cigarettes until the tax on approximately 0.5 grams of loose tobacco is<br />
equal to the tax on one cigarette.”<br />
“Authorize and implement First Nations tobacco taxes <strong>for</strong> 600+ First Nations. End tax<br />
deductibility <strong>for</strong> tobacco promotion expenses....Ensure that new urban reserves are<br />
required to implement a First Nations Tobacco Tax <strong>for</strong> sales of tobacco products.”<br />
Stakeholders also recommended using taxation as a means to reduce the cost of<br />
pharmacotherapies, as well as to shift tobacco users to less harmful tobacco products.<br />
“Remove GST from nicotine replacement products and prescription cessation products<br />
such as Zyban and Champix.”<br />
“Differential regulation and taxation of tobacco/nicotine products that put cigarettes at<br />
the greatest marketplace disadvantage.”<br />
25
Smoke-free policies (10 comments)<br />
A number of stakeholders recommended broader restrictions on <strong>smoking</strong>, including in<br />
outdoor areas, cars and households, as well as multi-unit dwellings.<br />
“Expanding smoke-free legislation to outdoor public places such as patios, doorways,<br />
parks, playgrounds and other recreation areas, and vehicles across Canada.”<br />
However, at least one stakeholder questioned whether more comprehensive <strong>smoking</strong><br />
restrictions would impact <strong>smoking</strong> rates:<br />
“Further restrictions on permitted locations <strong>for</strong> <strong>smoking</strong> (private vehicles, outdoor<br />
venues etc.) may be justified, but are unlikely to have much impact on <strong>smoking</strong><br />
prevalence."<br />
Reducing availability of tobacco and retail outlets (10 comments)<br />
There was strong consensus among stakeholders regarding the importance of <strong>reducing</strong><br />
the availability of tobacco products, mainly through a reduction in the number of retail<br />
outlets.<br />
“Experience with alcohol sale, among other products, shows that the number and ease<br />
of access to sales outlets has a significant effect on consumption. Currently, tobacco<br />
industry products are sold in over 17,000 outlets in Ontario, and many thousands<br />
more in other provinces. The number of outlets must be drastically reduced and all<br />
types of sale more effectively controlled.”<br />
“Severe restrictions on availability, making it a chore <strong>for</strong> people to find the product,<br />
accompanied by measures to curtail illicit activity.”<br />
Plain packaging (8 comments)<br />
Plain packaging was recommended as an important strategy <strong>for</strong> correcting false beliefs<br />
about tobacco products, <strong>for</strong> ―denormalizing‖ tobacco use, as well as restricting tobacco<br />
industry marketing. There was also support <strong>for</strong> prohibiting misleading brand descriptors,<br />
such as ―smooth‖ and ―slims‖ from packages.<br />
“Regulating tobacco packaging and marketing to minimise or eliminate any and all<br />
misleading or false assumptions on the dangers of tobacco (misleading descriptors,<br />
plain packaging, etc.)”<br />
“A law requiring plain/standardized packaging would strongly and quickly impact social<br />
norms regarding tobacco, and would likely also have a direct impact on smokers’<br />
opinions of their addiction.”<br />
26
Mass media campaigns & public education (8 comments)<br />
A number of stakeholders stressed the lack of effective mass media campaigns in<br />
Canada, as well as their importance in educating the public about the need <strong>for</strong> more<br />
comprehensive measures in other policy areas.<br />
“A sustained and compelling mass media campaign...”<br />
“Any and all of [other interventions] to be accompanied by large investments in public<br />
education and media campaigns.”<br />
“Have a clear and over-arching communications objective. This objective should be to<br />
“increase public appreciation <strong>for</strong> the need <strong>for</strong> government and societal initiatives to<br />
reduce tobacco use and its resulting harm”. The priority should not be to please<br />
people or to increase smokers’ desire to quit, but rather to shift public attitudes about<br />
tobacco products and tobacco manufacturers, about industry actions that increase<br />
tobacco use and about the effective measures that can be taken to reduce it.”<br />
“Tobacco industry denormalization (TID): a strategy to tell the public the truth about the<br />
tobacco industry’s role in the perpetuation of the epidemic in appropriate language<br />
including demonstration of why the industry falls outside the boundaries of normal<br />
business behaviour and recommended interventions to reverse the industry’s<br />
decades-long attempt to normalize its behaviour and products.”<br />
Health warnings (6 comments)<br />
Stakeholder recommendations <strong>for</strong> health warnings highlighted the need <strong>for</strong> larger<br />
warnings, more regular updates to the warnings, as well as linking the health warning<br />
campaign with other media interventions.<br />
“Stronger, larger and more compelling warnings would increase awareness of the true<br />
dangers of tobacco. Very large warnings would also reduce the normalization /<br />
glamorization generated by tobacco brands.”<br />
Marketing ban (5 comments)<br />
A number of stakeholders stressed the importance of en<strong>for</strong>cing existing<br />
restrictions on advertising and promotion, as well as the need <strong>for</strong> a<br />
complete ban on all <strong>for</strong>ms of tobacco marketing.<br />
“Implement a total ban on advertising/promotion.”<br />
“Ensure effective en<strong>for</strong>cement of [advertising and promotion restrictions<br />
under the ] Tobacco Act.”<br />
27
Product regulation (4 comments)<br />
Four stakeholders identified the need to place restrictions on tobacco products<br />
themselves. The main themes were the need to ban flavours, as well as to pursue<br />
reductions in the addictive potential of products by targeting nicotine, rather than ef<strong>for</strong>ts to<br />
reduce the harmfulness of conventional cigarettes.<br />
“Ban the sale of flavoured tobacco products.”<br />
“Regulations should prohibit any aspect of cigarette contents or design that promotes<br />
tobacco dependence and repeated use, including the use of flavours. Regulations<br />
should also consider restrictions on nicotine content”<br />
“Developing a national policy on nicotine, based on the risks of the delivery system.”<br />
Provision/Access to cessation services (12 comments)<br />
A strong majority of stakeholders recommended measures to improve the availability of<br />
cessation services and treatments to smokers, including disadvantaged groups. Many<br />
stakeholders stressed that existing levels of cessation support and access to cessation<br />
services in Canada is completely inadequate. Several stressed that focussing upon specific<br />
interventions was lower priority than developing a comprehensive, coordinated cessation<br />
system—these comments are included under the ―Systems & Tools‖ section. A number of<br />
stakeholders specifically mentioned subsidies to reduce the cost of pharmacotherapies as<br />
an important component of comprehensive cessation services.<br />
“Freely accessible <strong>smoking</strong> cessation pharmacotherapy. The great majority of <strong>adult</strong><br />
smokers are chronically dependent on tobacco and nicotine replacement therapy and<br />
medications such as varenicline and sustained-release buproprion will be required to<br />
achieve abstinence. Cost of these drugs is a significant barrier that must be removed.”<br />
“Differential regulation and taxation of tobacco/nicotine products that put cigarettes at<br />
the greatest marketplace disadvantage.”<br />
Greater focus on special populations (6 comments)<br />
Several stakeholders stressed the need to reach ―high burden‖ sub-populations and to<br />
ensure an equitable level of access to cessation services and support. Several comments in<br />
this area were linked to the need to subsidize the cost of <strong>smoking</strong> cessation in order to<br />
reduce the cost barrier <strong>for</strong> disadvantaged groups.<br />
28
“Rather than focus on <strong>smoking</strong> prevalence rates, switch attention to policies and<br />
practices which will have the greatest effect on expected future burden. Program<br />
providers tend to go after the "low hanging fruit who coincidently have the low future<br />
expected burden of tobacco related disease". The net effect is that groups that bare a<br />
greater proportion of the burden such as Aboriginals, persons with mental health<br />
problems, etc. tend to be left out of the research and practice equation.”<br />
“Greater access to free <strong>smoking</strong> cessation products and advice from health care<br />
providers, especially <strong>for</strong> lower SES and other key target groups”<br />
Novel/non-traditional therapy, including harm reduction (5 comments)<br />
Several stakeholders stressed the need to pursue non-traditional cessation therapies,<br />
particularly <strong>for</strong> smokers who fail to respond to conventional methods.<br />
“Testing and making available, where appropriate, new <strong>smoking</strong> cessation aids <strong>for</strong><br />
those that do not respond to NRTs and other traditional <strong>for</strong>ms of treatments<br />
(denicotinized cigarettes?, snus, e-cigarettes etc.)”<br />
“Distinguish between the drug & the delivery vehicle. Most smokers are seeking<br />
nicotine and were we to give alternative sources of the drug by non-combustion and<br />
medicinal sources we could drastically reduce <strong>smoking</strong> prevalence.”<br />
“A concerted ef<strong>for</strong>t at harm reduction...could have a substantial impact in the medium<br />
term. The two obstacles are regulatory inertia and the prohibitionist mindset of much<br />
of the tobacco control community. The latter may be insurmountable (though it would<br />
still be worth a try). Clear statements on relative risk and a substantial risk-based<br />
premium built into taxation would be two important steps to moving smokers to less<br />
hazardous products.”<br />
29
PRIORITIES FOR ACTION: SYSTEMS & TOOLS<br />
Stakeholders were also asked to suggest priorities <strong>for</strong> the development of ―systems‖ and<br />
―tools‖. There was considerable overlap in each of these areas with the themes and needs<br />
identified <strong>for</strong> specific interventions: more comprehensive policy and regulatory systems, as<br />
well as systems to improve the availability and use of cessation systems. The following<br />
section highlights unique comments specific to the development of systems and tools.<br />
Comprehensive, coordinated cessation system (10 comments)<br />
The most common theme related to ―systems‖ was the need to develop a more<br />
comprehensive <strong>smoking</strong> cessation system with expanded services and fewer barriers to<br />
access. There was a clear consensus among stakeholders that the existing level of<br />
cessation services is inadequate and an implicit sense that Canada is rapidly falling behind<br />
other jurisdictions in this critical area.<br />
“Any and all of [other interventions] need to be accompanied by a comprehensive<br />
<strong>smoking</strong> cessation system that will include a smokers' registry with proactive<br />
outreach to smokers offering tailored interventions and combinations of<br />
interventions.”<br />
“An integrated ef<strong>for</strong>t to promote cessation, including wider access to a wider range of<br />
NRT-type products and a thorough public education ef<strong>for</strong>t to dispel myths about<br />
nicotine.”<br />
“...integrated multi-level <strong>smoking</strong> cessation system incorporating all elements (media<br />
promotions, pharmacoptherapies, minimal through intensive interventions, intake<br />
and referral systems, smoker registries)...”<br />
“Despite years of discussion and some initiatives in some jurisdictions, there is still<br />
no comprehensive, readily-accessible cessation system available <strong>for</strong> all Canadians.<br />
Key elements of such a system include funding of stop-<strong>smoking</strong> medications <strong>for</strong> all<br />
those on low-income drug benefit plans; publication of the Smokers’ Helpline<br />
telephone numbers on all cigarette packages; much broader promotion of available<br />
services; implementation of Ottawa Heart Institute-type cessation protocols <strong>for</strong> all<br />
hospitals and similar health care facilities; mandated cessation counselling training<br />
<strong>for</strong> all health care professionals and allied professions.”<br />
“Establishment and co-ordination of a national level best practises system <strong>for</strong><br />
implementing and monitoring treatment that is consistent across jurisdictions.”<br />
“Consolidate ef<strong>for</strong>t (due to a variety of not unrelated factors, there are multiple<br />
sources of multiple initiatives, usually nickel and diming to the best of their ability<br />
with great intentions and little effect).”<br />
30
Better use of tool and training <strong>for</strong> health professionals (7 comments)<br />
A number of stakeholders emphasized the importance of developing tools <strong>for</strong> health<br />
professionals, as well as systems to promote the use of existing tools and resources that<br />
have already been developed. 47<br />
“Clinical Interventions - this is where Canada falls short. We have no clinical practice<br />
guidelines at national level and very poor availability of treatments...”<br />
“Tools to provide better guidance <strong>for</strong> primary care providers (family physicians, nurse<br />
practitioners, registered nurses, dentists etc) in providing <strong>smoking</strong> cessation support<br />
(better dissemination and uptake) -- skill development rather than knowledge<br />
dissemination.‖<br />
“A systems approach to <strong>smoking</strong> cessation that is embraced and implemented by all<br />
health practitioners, e.g., should be the same as checking blood pressure with every<br />
patient.”<br />
“Cessation counselling and brief intervention workshops <strong>for</strong> healthcare providers and<br />
workplaces.”<br />
“Systems to triage or match smokers with the most appropriate intervention to<br />
maximize resources and effectiveness of services.”<br />
Services <strong>for</strong> special populations (4 comments)<br />
Several stakeholders stressed the importance of developing a cessation system that meets<br />
the needs of high-burden ―special populations‖, including the need to tailor resources.<br />
““An Aboriginal tobacco control program that is not merely an adaptation of, or add-on<br />
to, that intended <strong>for</strong> general pop.”<br />
“Improve early education and support to pregnant women...”<br />
Knowledge exchange system (2 comments)<br />
Only two stakeholders referred to knowledge exchange systems and tools:<br />
“Ways to improve knowledge transfer amongst Canadians engaged in tobacco control<br />
ef<strong>for</strong>ts and between tobacco control and other social networks. Ways to improve<br />
knowledge transfer amongst federal government agencies regarding tobacco control.”<br />
“Better integration of research into treatment...”<br />
31
Better funding system <strong>for</strong> tobacco control (3 comments)<br />
Several stakeholders highlighted the importance of a stable and efficient funding system <strong>for</strong><br />
tobacco control.<br />
“With recent disbanding of CTCRI, we need mechanisms to maintain (and hopefully<br />
build) capacity in tobacco control research in Canada.”<br />
“Ef<strong>for</strong>ts to increase knowledge and expertise within Health Canada, and to link this<br />
issue to other public health issues.”<br />
“Funding <strong>for</strong> anti-tobacco groups should not solely be linked to projects. Core funding<br />
to promote tobacco control and respond to tobacco industry manipulation and<br />
misin<strong>for</strong>mation is essential, not just (or mainly) project funding. Organizations<br />
receiving funding should not be overburdened by reporting requirements, which<br />
currently represents a ridiculous workload. Provincial coalitions should be able to<br />
count on federal core funding, especially if provincial funding is weak.”<br />
32
PRIORITIES FOR ACTION: RESEARCH AND EVIDENCE<br />
Develop evidence base <strong>for</strong> new regulatory changes (11 comments)<br />
The most common research theme identified by stakeholders was the need to collect<br />
evidence to support the next generation of policies and regulations. The topic areas were<br />
fairly broad and similar to the themes identified under ―specific interventions‖.<br />
“A clearer idea of the relationship between tax levels, tax structure, and short-term and<br />
long-term impacts with respect to prevalence, disease levels, etc.”<br />
“Research evidence to plan, implement, monitor and evaluate strategies [including to]<br />
vastly reduce tobacco retail outlet density”<br />
“What messages and support systems encourage smokers, especially heavy<br />
smokers, to quit.”<br />
“...more research on non-drug cessation methods <strong>for</strong> individuals, and mass media<br />
campaigns <strong>for</strong> <strong>smoking</strong> cessation.”<br />
“Conduct studies on impact of generic packaging”<br />
“Research to understand the impact of regulations on nicotine content of products”<br />
Treatment delivery / provision of services (10 comments)<br />
Stakeholders identified a range of research needs <strong>for</strong> improving cessation services,<br />
including the reach and efficiency of these services.<br />
“Studies of the effectiveness of comprehensive cessations systems with proactive<br />
smokers' registries.”<br />
“What mix and dose of interventions would have the most impact in the shortest period<br />
of time (or at least in a three to five year time horizon). Do specific interventions<br />
produce synergistic, additive or subtractive effects when combined? I might also<br />
want to know what the minimum dose of specific interventions are required in order<br />
to be impactful. My rationale is that we don't need to know what interventions are<br />
most successful. Rather, we need to know which ones will likely have the most<br />
impact WITH THE EXPECTED LEVEL OF RESOURCES AVAILABLE.”<br />
“Developing an evidence base <strong>for</strong> treatment matching (which treatments are most<br />
likely to work <strong>for</strong> whom).”<br />
“Methods <strong>for</strong> “triaging” smokers to most appropriate level of intervention as a means to<br />
maximize the cost-effectiveness of cessation systems.<br />
33
Improve monitoring (8 comments)<br />
Stakeholders also highlighted the need <strong>for</strong> improved monitoring of key patterns and trends<br />
to evaluate existing initiatives, as well as to in<strong>for</strong>m future policies and programs. Several<br />
recommendations focussed on improved tracking of patterns of use, particularly quitting<br />
activities, and better understanding of the use of cessation services, while other<br />
stakeholders wanted to know more about ―hardcore‖ smokers and improve industry<br />
monitoring.<br />
Patterns of use and quitting<br />
“Though a fair bit has been written on whether there is a "hard core" of smokers that<br />
simply can't achieve abstinence, more info would be useful. What nicotine-specific (or<br />
tobacco-specific) needs do tobacco products meet, and are there practical<br />
alternatives?”<br />
“Increase awareness of what smokers know about relative risks of different tobacco and<br />
treatment products, including beliefs about smokeless tobacco and NRT. Compare<br />
beliefs to reality.”<br />
Product and Industry monitoring<br />
“Recent media and research articles report expansion in both marketing and/or use of<br />
both smokeless and non-traditional combustible products (such as hookahs/sheesha).<br />
E-cigarettes (devices which resemble cigarettes but which emit vaporized nicotine)<br />
are a more recent phenomenon. Acceptability, market penetration, and in some<br />
cases impacts on either health or addiction status of users, should be more carefully<br />
investigated <strong>for</strong> these products. Recent purchases of smokeless tobacco<br />
manufacturers by main-brand companies (e.g. USTC by Philip Morris) suggest the<br />
North American industry is planning expansion of non-cigarette products.”<br />
Research on novel/non-traditional treatments (3 comments)<br />
Several stakeholders indicated a need <strong>for</strong> evidence on non-traditional cessation<br />
interventions, including the use of potential ―harm-reduction‖ products.<br />
“Safety profile and efficacy of novel treatments such as denicotinized cigarettes, snus,<br />
e-cigarettes.”<br />
“...grow the body of evidence <strong>for</strong> "off-label" treatment using pharmacotherapy.”<br />
34
Improve understanding of special populations (5 comments)<br />
Additional evidence on the barriers to reach specific sub-populations of smokers was a<br />
common research theme.<br />
“The huge impact on the Aboriginal community: what are the socio-behavioural<br />
conditions that result in 50% – 70% <strong>smoking</strong> rates? Smoking is the norm in this<br />
context – how can that be countered?”<br />
“Impact in different high prevalence populations -- e.g. Aborginal, occupational groups<br />
(e.g. skilled labourers, truckers, miners), and cultural appropriateness of cessation.”<br />
“More analysis of nicotine self-medication in specific populations (some listed under<br />
“specific interventions”) and what this means.”<br />
Monitor the contraband situation more closely (5 comments)<br />
A number of stakeholders identified a need to collect independent evidence on the extent of<br />
illicit/contraband tobacco. Several stakeholders also requested in<strong>for</strong>mation on the likelihood<br />
that smokers will turn to illicit tobacco in response to other policy measures.<br />
“...objective studies to estimate size of contraband market.”<br />
“Smokers' reactions to the drastic measures and the likelihood that they will seek<br />
illegal sources. Ways to channel them to the cessation system rather than to illicit<br />
activity. Knowledge about advantages and disadvantages of varying degrees of<br />
staged (graduated) measures.”<br />
“As brand recognition/equity slowly disintegrate (or possibly quickly, once we have<br />
plain packaging), a critical thing will be to know what factors might keep tobacco<br />
users out of the illicit market. This is market research the large companies are almost<br />
certainly conducting already, but it would be good to have independent research to<br />
verify the industry's claim.”<br />
Expand training and capacity (2 comments)<br />
Two stakeholders highlighted the need <strong>for</strong> a greater investment in research capacity.<br />
“We need to promote Transdisciplinary networks and Centres like in US with<br />
NIDA/NIAAA/NCI TTURC's, and a better investment in training the next generation, if<br />
we are going to make progress - basic scientist, clinical and policy researchers need<br />
better communication, and more resources! ... the investment in tobacco research<br />
especially at basic science and clinical level is woefully inadequate “<br />
35
SUMMARY<br />
After decades of decline, <strong>smoking</strong> prevalence among <strong>adult</strong>s appears to have stagnated.<br />
This report includes a wide range of possible measures to decrease <strong>smoking</strong> prevalence.<br />
The primary theme of responses from stakeholders was that Canadian smokers are not<br />
receiving adequate services and support to quit <strong>smoking</strong>, and that Canada risks falling<br />
further behind in terms of regulations to reduce tobacco use. Stakeholders also expressed<br />
skepticism regarding the possibility that any of the proposed strategies could reduce<br />
prevalence to 12% by 2011 given the extremely short timeline. There was some level of<br />
consensus that the highest priority should be to invest in a comprehensive set of programs,<br />
policies, and services that may take longer to implement, but would have the potential to<br />
significantly reduce prevalence over the long term, rather than to rush to implement a<br />
handful of individual measures that are likely to be insufficient on their own.<br />
<strong>Priorities</strong> <strong>for</strong> short-term reductions in prevalence:<br />
Curb contraband tobacco and en<strong>for</strong>ce price and taxation measures<br />
Improve access and use of existing cessation services<br />
Renew commitment to comprehensive media campaigns<br />
<strong>Priorities</strong> <strong>for</strong> -term reductions in prevalence:<br />
Expand and coordinate cessation services<br />
En<strong>for</strong>ce existing regulations, particularly with respect to contraband sales of<br />
cigarettes<br />
Develop and implement the next generation of policies: more comprehensive<br />
marketing bans, greater sales/access restrictions, stronger taxation measures,<br />
plain packaging, product regulation<br />
Enhance partnerships with health professionals<br />
Develop new and ―alternative‖ cessation interventions<br />
Tailor cessation services to reach high-burden special populations<br />
Link policies, services and programs to a greater extent<br />
36
ADDITIONAL INFORMATION SOURCES<br />
Patterns and trends among Canadian smokers<br />
Physicians <strong>for</strong> a Smoke-Free Canada. Smoking in Canada: A statistical snapshot of<br />
smokers. 2005. Available at: http://www.smoke-free.ca/pdf_1/SmokinginCanada-2005.pdf<br />
The Lung Association. Making quit happen: Canada‘s Challenges to Smoking Cessation.<br />
2008. Available at: http://www.lung.ca/_resources/Making_quit_happen_report.pdf<br />
Reid JL, <strong>Hammond</strong> D, Driezen P. Socioeconomic status and <strong>smoking</strong> in Canada, 1999-<br />
2006: Has there been any progress on disparities in tobacco use? Submitted to the<br />
Canadian Journal of Public Health. Available on request.<br />
Comprehensive cessation services<br />
Bell K, McCullough L, Greaves L, et al. NICE Rapid Review: The Effectiveness of National<br />
Health Service Intensive Treatments <strong>for</strong> Smoking Cessation in England. 2007.<br />
NHS National Institute <strong>for</strong> Health and Clinical Excellence. Smoking cessation services in<br />
primary care, pharmacies, local authorities and workplaces, particularly <strong>for</strong> annual working<br />
groups, pregnant women and hard to reach communities. UK National Health Service. 2008.<br />
Available at: http://www.nice.org.uk/PH10<br />
Institute National De Sante Publique du Quebec. Remboursement des aides<br />
pharmacologiques a l‘arret tabagique au Quebec. Utilisation par less Quebecois assure par<br />
le regime public d‘assurance medicaments et couts associes: Phase II. 2007. Available at:<br />
http://www.inspq.qc.ca/pdf/publications/707-PCAPFinal.pdf<br />
National strategies from other countries<br />
Commonwealth of Australia. Tobacco Control in Australia: making <strong>smoking</strong> history.<br />
Prepared <strong>for</strong> the National Preventative Health Task<strong>for</strong>ce by the Tobacco Working Group.<br />
2008. Available at:<br />
http://www.preventativehealth.org.au/internet/preventativehealth/publishing.nsf/Content/96C<br />
AC56D5328E3D0CA2574DD0081E5C0/$File/tobacco-10octpdf.pdf<br />
UK Department of Health. Consultation on the future of tobacco control: consultation report.<br />
2008. Available at:<br />
http://www.dh.gov.uk/en/Consultations/Responsestoconsultations/DH_091382<br />
37
APPENDIX A: Stakeholder Comments – Specific Interventions<br />
Price measures: taxation and contraband<br />
“Tax/price increases, or maintaining current tax/price structure, will lead to biggest<br />
impact in prevalence in the short/medium/long-term. Lots of literature on this.”<br />
“Increasing taxation”<br />
“…of course, the issue of contra-band remains”<br />
“increase tobacco prices (and control contraband)”<br />
“address the smuggling problem…”<br />
“…raise tobacco taxes…”<br />
“<strong>reducing</strong> contraband cigarettes… and pricing/taxation”<br />
“Differential regulation and taxation of tobacco/nicotine products that put<br />
cigarettes at the greatest marketplace disadvantage.”<br />
“maintaining current high taxation rates, while substantially <strong>reducing</strong><br />
contraband and smuggling”<br />
“The most immediate impact would result from a hike in tobacco taxes – this<br />
despite the contraband problem. Most smokers still purchase their cigarettes<br />
from legal sources.”<br />
“Appropriate levels of taxation and measures to fight smuggling”<br />
“Ensure continued tobacco tax increases on a regular basis equivalent to or<br />
exceeding inflation… Increase taxes on roll-your-own (loose/RYO) tobacco<br />
proportionally more than manufactured cigarettes to equalize prices. Taxes<br />
on loose or RYO tobacco should be increased in proportionally greater<br />
amounts than manufactured cigarettes until the tax on approximately 0.5<br />
grams of loose tobacco is equal to the tax on one cigarette…”<br />
“Tax increases”<br />
“In light of the magnitude of the contraband problem in Quebec and Ontario<br />
(which hold the largest populations of smokers), aggressive contraband<br />
control is essential. Data from CTUMs, CCHS and YSS all show flattening of<br />
declines in prevalence: while this phenomenon is occurring nationwide (e.g.<br />
also in provinces with little or no contraband problem), available research<br />
strongly suggests that at least one-quarter of cigarettes now smoked in<br />
Ontario and Quebec – and perhaps considerably more – are contraband.<br />
RCMP and other seizures of contraband are dealing with 1-2% of the problem<br />
at best. No effective strategy to replace economic benefits of tobacco<br />
manufacturing in sale on First Nations reserves with “non-toxic” alternatives<br />
exists: until on-reserve manufacturing plants in New York State, Ontario and<br />
Quebec are shut down, problem will persist and likely grow.”<br />
“Aside from direct health impacts, contraband has led governments to avoid<br />
additional tax increases: there has been no federal tobacco tax increase<br />
38
since 2002, and no Ontario tobacco tax increase since 2006. Ontario and<br />
Quebec are the second-lowest and lowest-tobacco tax jurisdictions in<br />
Canada, respectively (which also demonstrates that contraband is a supplyside<br />
rather than a demand-side problem). Research has consistently<br />
demonstrated tobacco tax increases to be the single most effective<br />
intervention in <strong>reducing</strong> initiation and consumption.”<br />
“Unquestionably, making cigarettes less af<strong>for</strong>dable by raising the retail price<br />
through a substantial hike in tobacco taxes at both the federal and provincial<br />
levels.”<br />
“There needs to be cooperation and concerted action on a tax hike on the<br />
part of the feds, Ontario and Quebec. Part of the cooperation has to be a<br />
serious response to smuggling.”<br />
“Increase tobacco taxes <strong>for</strong> cigarettes, sticks, roll-your-own. For roll-your-own,<br />
there is a loophole that allows these products to be taxed at a lower rate<br />
than cigarettes… Authorize and implement First Nations tobacco taxes <strong>for</strong><br />
600+ First Nations… End tax deductibility <strong>for</strong> tobacco promotion<br />
expenses....Ensure that new urban reserves are required to implement a First<br />
Nations Tobacco Tax <strong>for</strong> sales of tobacco products... Remove GST from<br />
nicotine replacement products and prescription cessation products such as<br />
Zyban and Champix.”<br />
“Eliminate illegal production on the U.S. side of the Akwesasne/St. Regis<br />
reserve… Eliminate illegal production on some Canadian reserves…”<br />
“Eliminating contraband tobacco, which will reduce consumption by<br />
effectively increasing price and encourage cessation.”<br />
“Big price increases (i.e. through taxes) accompanied by measures to curtail<br />
contraband.”<br />
“Controlling contraband and raising tobacco taxes”<br />
“Controlling the illicit market and raising prices. In the short term,<br />
nothing else will have much effect.”<br />
“Specific interventions to increase social control include development of:<br />
community norms that the sale of contraband cigarettes is not a victimless<br />
crime”<br />
Smoke-free policies<br />
“Continue to expand restrictions on <strong>smoking</strong> (e.g. <strong>smoking</strong> bans in households<br />
with children)”<br />
“Stonger/enhanced restrictions on second-hand smoke (e.g., apartment<br />
buildings, beaches, patios in bars/restaurants, employee-only DSRs, etc).”<br />
“continued high profile legislation that impacts social norms (legislation to reduce<br />
<strong>smoking</strong> in cars)”<br />
39
“…bans on <strong>smoking</strong> in other places (MUDs including hotels/motels, outdoors)”<br />
“expanding smoke-free legislation to outdoor public places such as patios,<br />
doorways, parks, playgrounds and other recreation areas, and vehicles<br />
across Canada… Smoke free multi-unit housing is also important but I think this<br />
has to be done through a voluntary approach rather than through legislation<br />
in the short term and perhaps the climate will be right <strong>for</strong> a legislative<br />
approach in long-term.”<br />
“Bans on <strong>smoking</strong> in workplaces and all public places where there are none.”<br />
“Protection from secondhand smoke (smoke-free environments)… Ban<br />
<strong>smoking</strong> in outdoor areas such as patios and school grounds.”<br />
“Gradually <strong>reducing</strong> the number of places people can smoke, e.g.,<br />
eliminating <strong>smoking</strong> in parks, on beaches, etc… Eliminating <strong>smoking</strong> in social<br />
housing (and other multi-unit dwellings)”<br />
“Bans on outdoor <strong>smoking</strong>…Bans on <strong>smoking</strong> in MUDS.”<br />
“Further restrictions on permitted locations <strong>for</strong> <strong>smoking</strong> (private<br />
vehicles, outdoor venues etc.) may be justified, but are unlikely to have much<br />
impact on <strong>smoking</strong> prevalence.”<br />
Reducing availability of tobacco and retail outlets<br />
“I also think availability is an important factor in <strong>adult</strong> <strong>smoking</strong> prevalence<br />
and associated interventions would include… continuing work on disparities in<br />
access to cigarettes through POS”<br />
“Expand and en<strong>for</strong>ce restrictions on tobacco promotion and sales… Expand<br />
restrictions on tobacco sales.”<br />
“Address tobacco sales and outlet density…”<br />
“Experience with alcohol sale, among other products, shows that the number<br />
and ease of access to sales outlets has a significant effect on consumption.<br />
Currently, tobacco industry products are sold in over 17,000 outlets in Ontario,<br />
and many thousands more in other provinces. The number of outlets must be<br />
drastically reduced and all types of sale more effectively controlled.”<br />
“Severe restrictions on availability, making it a chore <strong>for</strong> people to find the<br />
product, accompanied by measures to curtail illicit activity.”<br />
“Specific interventions to increase social control include development of:<br />
community norms opposed to selling tobacco products in 'normal'<br />
environments like convenience stores”<br />
“Restrictions on density of retail outlets, or transfer of tobacco outlets to singlepurpose<br />
outlets, may well backfire by further encouraging illicit trade and<br />
creating a smaller (but still quite large) constituency in the retail sector that is<br />
completely dependent on tobacco sales.”<br />
“vastly reduce tobacco retail outlet density”<br />
“Restrictions or bans on activities which encourage or induce <strong>smoking</strong><br />
(including retail and other promotions) “<br />
40
“Prohibit tobacco sales in pharmacies, universities and colleges, bars and<br />
restaurants, athletic and recreational facilities, and through vending<br />
machines.”<br />
Plain packaging<br />
“Population based approaches have not been exhausted yet. We need to<br />
look at plain packaging next.”<br />
“Plain packaging and anything that prevents use of the pack or other<br />
'stretched' advertising”<br />
“…plain packs…”<br />
“A law requiring plain/standardized packaging would strongly and quickly<br />
impact social norms regarding tobacco, and would likely also have a direct<br />
impact on smokers‟ opinions of their addiction… Regulating tobacco<br />
packaging and marketing to minimise or eliminate any and all misleading or<br />
false assumptions on the dangers of tobacco (misleading descriptors, plain<br />
packaging, etc.)”<br />
“Require plain packaging.”<br />
“Implementation of plain packaging”<br />
“Introducing generic packaging”<br />
“Plain packaging is worth doing <strong>for</strong> various reasons, in particular to diminish<br />
misconceptions about relative harm of different cigarette brands and to<br />
reduce the attractiveness of cigs <strong>for</strong> teens. However, neither effect is likely to<br />
be very large or very rapid on a population level.”<br />
Mass media campaigns & public education<br />
“Public campaigns about the potential dangers of 3rd hand smoke (e.g.<br />
could hugging your child after being exposed to tobacco smoke have<br />
negative health consequences <strong>for</strong> them?)”<br />
“implement evidence-based mass media campaigns”<br />
“An integrated ef<strong>for</strong>t to promote cessation, including wider access to a wider<br />
range of NRT-type products and a thorough public education ef<strong>for</strong>t to dispel<br />
myths about nicotine. This needs to include ef<strong>for</strong>ts by Health Canada to end<br />
its own actions that demonize nicotine. A proper understanding of nicotine<br />
and the role NRT can play in <strong>smoking</strong> cessation is important in order to get<br />
those making quit attempts to use as much NRT as they should <strong>for</strong> as long as<br />
they should in order to best stay off cigarettes.”<br />
“mass media quit campaigns combined with quit-lines”<br />
“Have a clear and over-arching communications objective. This objective<br />
should be to „increase public appreciation <strong>for</strong> the need <strong>for</strong> government and<br />
41
societal initiatives to reduce tobacco use and its resulting harm‟. The priority<br />
should not be to please people or to increase smokers‟ desire to quit, but<br />
rather to shift public attitudes about tobacco products and tobacco<br />
manufacturers, about industry actions that increase tobacco use and about<br />
the effective measures that can be taken to reduce it… Illustrate the scope<br />
and nature of the tobacco epidemic to Canadians. This in<strong>for</strong>mation should<br />
be presented in ways appropriate to the scale of the harm that has been<br />
caused, and with a view to sparking the type of discussion that leads to social<br />
norm change. Canadians should understand the size and devastation of the<br />
tobacco epidemic, especially in comparison to other feared risks, such as<br />
SARS, West Nile virus, car accidents, AIDS and so on.”<br />
“Implement a strategic mass media/counter-advertising campaign to support<br />
young <strong>adult</strong>s and at-risk populations.”<br />
“Tobacco industry denormalization (TID): a strategy to tell the public the truth<br />
about the tobacco industry‟s role in the perpetuation of the epidemic in<br />
appropriate language including demonstration of why the industry falls<br />
outside the boundaries of normal business behaviour and recommended<br />
interventions to reverse the industry‟s decades-long attempt to normalize its<br />
behaviour and products. The Ontario Tobacco Research Unit should be asked<br />
to produce a summary report of options <strong>for</strong> introducing TID as a mass media<br />
intervention under the SFOS.”<br />
“Public awareness campaign on the use of tobacco product packaging as<br />
advertising and the advantage of plain packaging… Public awareness<br />
campaign on contraband tobacco and organized crime”<br />
“Any and all of [other interventions] to be accompanied by large investments<br />
in public education and media campaigns.”<br />
“Conducting nationwide public campaigns in support of these policies”<br />
Health warnings<br />
“implement a comprehensive cessation system that is well integrated with<br />
mass media campaigns and warning labels”<br />
“…effective warnings…”<br />
“Stronger, larger and more compelling warnings would increase awareness of<br />
the true dangers of tobacco. Very large warnings would also reduce the<br />
normalization / glamorization generated by tobacco brands.”<br />
“Ensure next round of package warnings is as effective as possible… Require<br />
a health warning or other message directly on the cigarette.”<br />
“New package warnings – and a timetable <strong>for</strong> regularly changing them (not<br />
just rotating them, but refreshing them every X years)”<br />
“Changing and improving health warnings on tobacco packaging”<br />
Marketing ban<br />
42
“Stronger/enhanced restrictions (or complete prohibition) of all tobacco-related<br />
marketing.”<br />
“Restrictions or bans on activities which encourage or induce <strong>smoking</strong>…”<br />
“Expand and en<strong>for</strong>ce restrictions on tobacco promotion and sales”<br />
“Implement a total ban on advertising/promotion…Require warnings on<br />
permitted advertising/promotion in interim period until a total ban is in<br />
place…Ensure that there is a federal ban on retail displays, through adoption<br />
of measures in Tobacco Promotion Regulations, or amendments to the<br />
Tobacco Act….Ensure effective en<strong>for</strong>cement of [advertising and promotion<br />
restrictions under the] Tobacco Act….Respond to violations of tobacco<br />
industry advertising codes.”<br />
“Introducing total ban on advertising and promotion”<br />
Product regulation<br />
“A ban on flavours as well as single sale / mini packs of cigarillos (or any other<br />
product that resembles cigarettes) would have an immediate impact on<br />
youth and young <strong>adult</strong>s, since this is the product of choice <strong>for</strong> many (in fact<br />
<strong>for</strong> the majority of youths in Quebec). There is no evidence that occasional<br />
smokers of flavoured cigars would automatically turn to other tobacco<br />
products.”<br />
“Ban the sale of flavoured tobacco products”<br />
“Developing a national policy on nicotine, based on the risks of the delivery<br />
system.”<br />
“Regulations should prohibit any aspect of cigarette contents or design that<br />
promotes tobacco dependence and repeated use, including the use of<br />
flavours. Regulations should also consider restrictions on nicotine content”<br />
Provision/Access to cessation services<br />
“Testing and making available, where appropriate, new <strong>smoking</strong> cessation<br />
aids <strong>for</strong> those that do not respond to NRTs and other tradtional <strong>for</strong>ms of<br />
treatments (denicotinized cigarettes?, snus, e-cigarettes etc.)…Health care<br />
reimbursement <strong>for</strong> <strong>smoking</strong> cessation treatments”<br />
“Freely accessible <strong>smoking</strong> cessation pharmacotherapy. The great majority<br />
of <strong>adult</strong> smokers are chronically dependent on tobacco and nicotine<br />
replacement therapy and medications such as varenicline and sustainedrelease<br />
buproprion will be required to achieve abstinence. The cost of these<br />
drugs is a significant barrier that must be removed.”<br />
“We have no clinical practice guidelines at national level and very poor<br />
availability of treatments”<br />
“…campaigns combined with quit-lines”<br />
“Expand, promote and provide greater funding to a „quit line‟ <strong>for</strong> <strong>smoking</strong><br />
cessation.”<br />
43
“Greater access to free <strong>smoking</strong> cessation products and advice from health<br />
care providers, especially <strong>for</strong> lower SES and other key target groups”<br />
“…with proactive outreach to smokers offering tailored interventions and<br />
combinations of interventions.”<br />
“Differential regulation and taxation of tobacco/nicotine products that put<br />
cigarettes at the greatest marketplace disadvantage.”<br />
“Population-based <strong>smoking</strong> cessation programs, in conjunction with widely<br />
available individual programs.”<br />
“cessation interventions <strong>for</strong> parents that go far beyond pharmacotherapy”<br />
“implement a comprehensive cessation system…”<br />
“integrated multi-level <strong>smoking</strong> cessation system incorporating all elements<br />
(media promotions, pharmacoptherapies, minimal through intensive<br />
interventions…”<br />
Novel/non-traditional therapy, including harm reduction<br />
“Testing and making available, where appropriate, new <strong>smoking</strong> cessation<br />
aids <strong>for</strong> those that do not respond to NRTs and other tradtional <strong>for</strong>ms of<br />
treatments (denicotinized cigarettes?, snus, e-cigarettes etc.)”<br />
“Distinguish between the drug & the delivery vehicle. Most smokers are<br />
seeking nicotine and were we to give alternative sources of the drug by noncombustion<br />
and medicinal sources we could drastically reduce <strong>smoking</strong><br />
prevalence.”<br />
“Explore alternatives to <strong>smoking</strong>”<br />
“A concerted ef<strong>for</strong>t at harm reduction, either via snus or a Nigel Grey-style<br />
"highly addictive NRT", could have a substantial impact in the medium term.<br />
The two obstacles are regulatory inertia and the prohibitionist mindset of<br />
much of the tobacco control community. The latter may be insurmountable<br />
(though it would still be worth a try). Clear statements on relative risk and a<br />
substantial risk-based premium built into taxation would be two important<br />
steps to moving smokers to less hazardous products.”<br />
“…by giving alternative sources of nicotinics or simply alternative therapies”<br />
Greater focus on special populations<br />
“Clinical Interventions… including <strong>for</strong> special populations (mentally ill,<br />
addicted, chronic pain, pregnancy etc).”<br />
“Special ef<strong>for</strong>ts to deal with those who are evidently self-medicating with<br />
nicotine to treat a wide range of conditions (schizophrenia, depression,<br />
Tourette's, ADHD, anxiety disorders, etc.) by giving alternative sources of<br />
nicotinics or simply alternative therapies.”<br />
“…Program providers tend to go after the "low hanging fruit who coincidently<br />
have the low future expected burden of tobacco related disease". The net<br />
effect is that groups that bare a greater proportion of the burden such as<br />
44
Aboriginals, persons with mental health problems, etc. tend to be left out of<br />
the research and practice equation”<br />
“Implement a strategic mass media/counter-advertising campaign to support<br />
young <strong>adult</strong>s and at-risk populations.”<br />
“…especially <strong>for</strong> lower SES and other key target groups”<br />
45
APPENDIX B: Stakeholder Feedback – Systems and Tools<br />
Comprehensive, coordinated cessation system<br />
“Establishment and co-ordination of a national level best practises system <strong>for</strong><br />
implementing and monitoring treatment that is consistent across jurisdictions.”<br />
“Consolidate ef<strong>for</strong>t (due to a variety of not unrelated factors, there are<br />
multiple sources of multiple initiatives, usually nickel and diming to the best of<br />
their ability with great intentions and little effect).”<br />
“In cessation, systematic intervention across health care systems will move<br />
things <strong>for</strong>ward (eg. Ottawa Model )”<br />
“We don't always know what each other are doing, so might be useful to<br />
have a national research bank or knowledge exchange network... perhaps<br />
we already have this in various <strong>for</strong>ms, but I don't think existing networks are<br />
well used or sustainable in long term and there is much overlap”<br />
“…ways to improve knowledge transfer amongst Canadians engaged in<br />
tobacco control ef<strong>for</strong>ts and between tobacco control and other social<br />
networks… ways to improve knowledge transfer amongst federal government<br />
agencies regarding tobacco control (a 'whole of government' approach)<br />
and between levels of Canadian governments”<br />
“Improved communication between the various health delivery sectors<br />
involved in <strong>smoking</strong> cessation”<br />
“Any and all of these to be accompanied by a comprehensive <strong>smoking</strong><br />
cessation system that will include a smokers' registry with proactive outreach<br />
to smokers offering tailored interventions and combinations of interventions.”<br />
“An integrated ef<strong>for</strong>t to promote cessation, including wider access to a wider<br />
range of NRT-type products and a thorough public education ef<strong>for</strong>t to dispel<br />
myths about nicotine…”<br />
“integrated multi-level <strong>smoking</strong> cessation system incorporating all elements<br />
(media promotions, pharmacoptherapies, minimal through intensive<br />
interventions, intake and referral systems, smoker registries..”<br />
“Despite years of discussion and some initiatives in some jurisdictions, there is<br />
still no comprehensive, readily-accessible cessation system available <strong>for</strong> all<br />
Canadians. Key elements of such a system include funding of stop-<strong>smoking</strong><br />
medications <strong>for</strong> all those on low-income drug benefit plans; publication of the<br />
Smokers‟ Helpline telephone numbers on all cigarette packages; much<br />
broader promotion of available services; implementation of Ottawa Heart<br />
Institute-type cessation protocols <strong>for</strong> all hospitals and similar health care<br />
facilities; mandated cessation counselling training <strong>for</strong> all health care<br />
professionals and allied professions.”<br />
46
Better use of tool and training <strong>for</strong> health professionals<br />
“Tools to provide guidance <strong>for</strong> primary care providers (family physicians, nurse<br />
practitioners, registered nurses, dentists etc) in providing <strong>smoking</strong> cessation<br />
support (better dissemination and uptake) -- skill development rather than<br />
knowledge dissemination”<br />
“Implementation needs to be supported by training and technical<br />
assistance”<br />
“Despite years of discussion and some initiatives in some jurisdictions, there is<br />
still no comprehensive, readily-accessible cessation system available <strong>for</strong> all<br />
Canadians. Key elements of such a system include…mandated cessation<br />
counselling training <strong>for</strong> all health care professionals and allied professions.”<br />
“Capacity building, particularly among health professionals, bureaucrats<br />
working in tobacco control, and public policy advocates (in that order)”<br />
“Cessation counselling and brief intervention workshops <strong>for</strong> healthcare<br />
providers and workplaces”<br />
“Clinical Interventions - this is where Canada falls short. We have no clinical<br />
practice guidelines at national level and very poor availability of<br />
treatments...”<br />
“A systems approach to <strong>smoking</strong> cessation that is embraced and<br />
implemented by all health practitioners, e.g., should be the same as checking<br />
blood pressure with every patient.”<br />
Services <strong>for</strong> special populations<br />
“Specifically – an Aboriginal tobacco control program that is not merely an<br />
adaptation of, or add-on to, that intended <strong>for</strong> general pop.”<br />
“How best to work with Aboriginal peoples on all aspects of tobacco control,<br />
including contraband issues”<br />
“Improve early education and support to pregnant women”<br />
“Addition of <strong>smoking</strong> cessation component <strong>for</strong> treatment of high risk<br />
populations <strong>for</strong> other problems (e.g. addictions, mental health)”<br />
Knowledge exchange system<br />
“Ways to improve knowledge transfer amongst Canadians engaged in<br />
tobacco control ef<strong>for</strong>ts and between tobacco control and other social<br />
networks. Ways to improve knowledge transfer amongst federal government<br />
agencies regarding tobacco control.”<br />
“Better integration of research into treatment...”<br />
47
Better funding system <strong>for</strong> tobacco control<br />
“With recent disbanding of CTCRI, we need mechanisms to maintain (and<br />
hopefully build) capacity in tobacco control research in Canada.”<br />
“Ef<strong>for</strong>ts to increase knowledge and expertise within Health Canada, and to<br />
link this issue to other public health issues.”<br />
“Funding <strong>for</strong> anti-tobacco groups should not solely be linked to projects. Core<br />
funding to promote tobacco control and respond to tobacco industry<br />
manipulation and misin<strong>for</strong>mation is essential, not just (or mainly) project<br />
funding. Organizations receiving funding should not be overburdened by<br />
reporting requirements, which currently represents a ridiculous workload.<br />
Provincial coalitions should be able to count on federal core funding,<br />
especially if provincial funding is weak.”<br />
48
APPENDIX C: Stakeholder Feedback – Research and Evidence<br />
Develop evidence base <strong>for</strong> new regulatory changes<br />
“much work needs to be done: obtain evidence to plan, implement,<br />
monitor and evaluate the following strategies:<br />
increase tobacco prices (and control contraband)<br />
vastly reduce tobacco retail outlet density<br />
implement evidence-based mass media campaigns<br />
implement a comprehensive cessation system that is well integrated<br />
with mass media campaigns and warning labels”<br />
“more research should be done on the impact on <strong>smoking</strong> initiation in the<br />
following areas: comprehensive tobacco control program that includes<br />
education, clinical interventions, regulatory measures, economic<br />
approaches and social strategies, expanding smoke-free legislation to<br />
outdoor public places, smoke free multi-unit housing, <strong>reducing</strong> contraband<br />
cigarettes, continuing work on disparities in access to cigarettes through<br />
POS, and pricing/taxation”<br />
“applied research to test mass media campaign ideas and concepts…ongoing<br />
evaluation research to test efficacy of mass media interventions”<br />
“Public opinion polling on the new warnings… A legal opinion on the<br />
feasibility of plain packaging…Public opinion polling on plain packaging<br />
(be<strong>for</strong>e and after an awareness campaign)”<br />
“Conduct studies on impact of generic packaging”<br />
“A clearer idea of the relationship between tax levels, tax structure, and<br />
short-term and long-term impacts with respect to prevalence, disease<br />
levels, etc.”<br />
“Research evidence to plan, implement, monitor and evaluate strategies<br />
[including to] vastly reduce tobacco retail outlet density”<br />
“What messages and support systems encourage smokers, especially<br />
heavy smokers, to quit.”<br />
“There needs to be more research on non-drug cessation methods <strong>for</strong><br />
individuals, and mass media campaigns <strong>for</strong> <strong>smoking</strong> cessation.”<br />
“Research to understand the impact of regulations on nicotine content of<br />
products”<br />
49
Treatment delivery/provision of services<br />
“Studies of the effectiveness of comprehensive cessations systems with<br />
proactive smokers' registries.”<br />
“obtain evidence to plan, implement, monitor and evaluate the following<br />
strategies: …implement a comprehensive cessation system that is well<br />
integrated with mass media campaigns and warning labels”<br />
“What mix and dose of interventions would have the most impact in the<br />
shortest period of time (or at least in a three to five year time horizon). Do<br />
specific interventions produce synergistic, additive or subtractive effects<br />
when combined? I might also want to know what the minimum dose of<br />
specific interventions are required in order to be impactful. My rationale is<br />
that we don't need to know what interventions are most successful. Rather,<br />
we need to know which ones will likely have the most impact WITH THE<br />
EXPECTED LEVEL OF RESOURCES AVAILABLE.”<br />
“Methods <strong>for</strong> “triaging” smokers to most appropriate level of intervention as<br />
a means to maximize the cost-effectiveness of cessation systems.”<br />
“Developing an evidence base <strong>for</strong> treatment matching (which treatments<br />
are most likely to work <strong>for</strong> whom)”<br />
“There needs to be more research on non-drug cessation methods <strong>for</strong><br />
individuals, and mass media campaigns <strong>for</strong> <strong>smoking</strong> cessation. “<br />
Monitoring: Patterns of use and quitting<br />
“Though a fair bit has been written on whether there is a "hard core" of<br />
smokers that simply can't achieve abstinence, more info would be useful.<br />
What nicotine-specific (or tobacco-specific) needs do tobacco products<br />
meet, and are there practical alternatives?”<br />
“Increase awareness of what smokers know about relative risks of different<br />
tobacco and treatment products, including beliefs about smokeless<br />
tobacco and NRT. Compare beliefs to reality [then blush . . .]”<br />
“Better treatment monitoring so that we understand what works when <strong>for</strong><br />
whom… Increased attention on understanding <strong>for</strong>mer smokers; how did<br />
they quit, what were biggest challenges etc.”<br />
“In area of cessation, we need to grow the body of evidence <strong>for</strong> "off-label"<br />
treatment using pharmacotherapy.”<br />
“We need more accurate assessments of <strong>smoking</strong> rates and trends.<br />
Telephone surveys are no longer particularly reliable. We certainly need to<br />
stop pretending that gross under-reporting of consumption is not an issue,<br />
and must end the delusion that 'reported prevalence' is actual<br />
prevalence..”<br />
50
“Health care providers, and public, awareness of the effects of quitting, use<br />
and effectiveness of cessation medications... <strong>Best</strong> practice evidence <strong>for</strong><br />
cessation programs”<br />
Product and Industry monitoring<br />
“The impact of the tobacco industry‟s renewed advertising ef<strong>for</strong>ts on<br />
consumption, especially among teens and young <strong>adult</strong>s”<br />
“Continued monitoring of tobacco industry marketing activities”<br />
“Recent media and research articles report expansion in both marketing<br />
and/or use of both smokeless and non-traditional combustible products<br />
(such as hookahs/sheesha). E-cigarettes (devices which resemble<br />
cigarettes but which emit vaporized nicotine) are a more recent<br />
phenomenon. Acceptability, market penetration, and in some cases<br />
impacts on either health or addiction status of users, should be more<br />
carefully investigated <strong>for</strong> these products. Recent purchases of smokeless<br />
tobacco manufacturers by main-brand companies (e.g. USTC by Philip<br />
Morris) suggest the North American industry is planning expansion of noncigarette<br />
products.”<br />
Research on novel/non-traditional treatments<br />
“Safety profile and efficacy of novel treatments such as denicotinized<br />
cigarettes, snus, e-cigarettes”<br />
“…grow the body of evidence <strong>for</strong> "off-label" treatment using<br />
pharmacotherapy.”<br />
Improve understanding of special populations<br />
“The huge impact on the Aboriginal community: what are the sociobehavioural<br />
conditions that result in 50% – 70% <strong>smoking</strong> rates? Smoking is<br />
the norm in this context – how can that be countered?”<br />
“We need more research $$ directed to Clinical Studies and special<br />
populations (e.g. mental health and addictions subset of smokers”<br />
“Impact in different high prevalence populations -- e.g. Aborginal,<br />
occupational groups (e.g. skilled labourers, truckers, miners), and cultural<br />
appropriateness of cessation”<br />
“More analysis of nicotine self-medication in specific populations and what<br />
this means. For instance, I estimate that schizophrenics are now likely<br />
51
accounting <strong>for</strong> over 10% of all cigarettes smoked in Canada, but they are<br />
not being addressed.”<br />
“How to reach the hard to reach?... Empower people who feel<br />
disenfranchised and see <strong>smoking</strong> as the only pleasure/escape in life.”<br />
Monitor the contraband situation more closely<br />
“First, independent evaluation of the GfK contraband studies carried out<br />
<strong>for</strong> the Canadian Tobacco Manufacturers Council in 2006-08 is needed. If<br />
these studies are validated, their conclusions can then be adopted as<br />
acceptable evidence of the extent of the contraband problem. If they<br />
are not validated, appropriate similar studies need to be carried out on an<br />
urgent basis in all provinces, with special attention to Ontario and Quebec,<br />
to determine the exact extent and nature of the contraband problem and<br />
its likely future growth patterns.”<br />
“A better handle on contraband activities and sales…The impact of<br />
contraband tobacco on consumption by age cohort”<br />
“Smokers' reactions to the drastic measures and the likelihood that they will<br />
seek illegal sources. Ways to channel them to the cessation system rather<br />
than to illicit activity. Knowledge about advantages and disadvantages of<br />
varying degrees of staged (graduated) measures…Studies of likely<br />
developments in illicit activity and how this can be addressed.”<br />
“Conduct objective studies to estimate size of contraband market”<br />
“As brand recognition/equity slowly disintegrate (or possibly quickly, once<br />
we have plain packaging), a critical thing will be to know what factors<br />
might keep tobacco users out of the illicit market. This is market research<br />
the large companies are almost certainly conducting already, but it would<br />
be good to have independent research to verify the industry's claim.<br />
Examples:<br />
1) How effective are scare tactics about illicit product likely to be<br />
(rat droppings etc.), given their somewhat dubious factual basis?<br />
2) Is consistency in taste and other characteristics something that<br />
smokers are willing to pay a high premium <strong>for</strong>? Do they get that from<br />
illicit product?”<br />
52
Expand training and capacity<br />
“We need more research $$ direct to Clinical Studies and special<br />
populations (e.g. mental health and addictions subset of smokers). We<br />
need to promote Transdisciplinary networks and Centres like in US with<br />
NIDA/NIAAA/NCI TTURC's, and a better investment in training the next<br />
generation, if we are going to make progress - basic scientist, clinical and<br />
policy researchers need better communication, and more resources!”<br />
“Awareness and development of cessation counselling practices among<br />
healthcare providers”<br />
53
REFERENCES<br />
1 Canadian Tobacco Use Monitoring Survey, 1999-2007. Available online at: http://www.hcsc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/index-eng.php#ctums.<br />
2 Canadian Tobacco Use Monitoring Survey, February – June 2008. Available online at:<br />
http://www.hc-sc.gc.ca/hl-vs/tobac-tabac/research-recherche/stat/index-eng.php#ctums.<br />
3 Reid JL, <strong>Hammond</strong> D, Driezen P. Socioeconomic status and <strong>smoking</strong> in Canada, 1999-2006:<br />
Has there been any progress on disparities in tobacco use? Can J Public Health (Under<br />
Review).<br />
4 Physicians <strong>for</strong> a Smoke-Free Canada. Smoking in Canada: A statistical snapshot of smokers. 2005.<br />
[Original data from the Canadian Community Health Survey, 2005]. Available online at:<br />
http://www.smoke-free.ca/pdf_1/SmokinginCanada-2005.pdf.<br />
5 Kotz D, West R. Explaining the social gradient in <strong>smoking</strong> cessation: it's not in the trying, but<br />
in the succeeding. Tob Control 2009;18(1):43-6.<br />
6 Callery WE, <strong>Hammond</strong> D, Reid JL, Fong GT, Borland R, Cummings KM. Socioeconomic<br />
variation in the reach of various sources of anti-<strong>smoking</strong> in<strong>for</strong>mation: Findings from the ITC 4-<br />
Country survey. In preparation.<br />
7 Reid JL. Are Patterns of Smoking Cessation and Related Behaviours Associated with<br />
Socioeconomic Status? An Analysis of Data from the International Tobacco Control Four Country<br />
Survey [thesis]. 2008. Waterloo: University of Waterloo. URI: http://hdl.handle.net/10012/4012.<br />
8 Brewster JM, Victor JC, Ashley MJ.Views of Ontarians about health professionals' <strong>smoking</strong><br />
cessation advice. Can J Public Health 2007;98(5):395-9.<br />
9 <strong>Hammond</strong> D, Reid J, Driezen P, Cummings KM, Borland R, Fong, GT, McNeill A. Use of<br />
nicotine replacement therapy <strong>for</strong> reasons other than stopping <strong>smoking</strong>: Findings from the ITC<br />
Policy Evaluation Survey. Addiction 2008;103:1696–1703.<br />
10 Cunningham JA, Selby PL. Intentions of smokers to use free nicotine replacement therapy.<br />
CMAJ 2008;179(2):145-6.<br />
11 Fong GT, Cummings KM, Borland R, <strong>Hammond</strong> D, et al. ITC 4-Country Survey Wave 6:<br />
Unpublished findings.<br />
12 <strong>Hammond</strong> D, Fong GT, McDonald PW, Borland R. Do Smokers Know How to Quit?<br />
Knowledge and Adoption of Cessation Assistance in a Representative Sample of Daily<br />
Smokers. Addiction 2004;99(8):1042-48.<br />
13 Lancaster T, Stead LF. Self-help interventions <strong>for</strong> <strong>smoking</strong> cessation. Cochrane Database of<br />
Systematic Reviews 2005;Issue 3. Art. No.: CD001118. DOI:<br />
10.1002/14651858.CD001118.pub2.<br />
14 Cahill K, Perera R. Competitions and incentives <strong>for</strong> <strong>smoking</strong> cessation. Cochrane Database<br />
of Systematic Reviews 2008;Issue 3. Art. No.: CD004307. DOI:<br />
10.1002/14651858.CD004307.pub3.<br />
15 Bala M, Strzeszynski L, Cahill K. Mass media interventions <strong>for</strong> <strong>smoking</strong> cessation in <strong>adult</strong>s.<br />
Cochrane Database of Systematic Reviews 2008;Issue 1. Art. No.: CD004704. DOI:<br />
10.1002/14651858.CD004704.pub2.<br />
16 U.S. National Cancer Institute. The role of the media in promoting and <strong>reducing</strong> tobacco use.<br />
Tobacco Control Monograph 19. Bethesda, MD: U.S. Department of Health and Human<br />
Services, National Institutes of Health, National Cancer Institute, 2008. Available online at:<br />
http://www.cancercontrol.cancer.gov/tcrb/monographs/19/index.html.<br />
54
17 Lancaster T, Stead LF. Individual behavioural counselling <strong>for</strong> <strong>smoking</strong> cessation. Cochrane<br />
Database of Systematic Reviews 2005;Issue 2. Art. No.: CD001292. DOI:<br />
10.1002/14651858.CD001292.pub2.<br />
18 Stead LF, Lancaster T. Group behaviour therapy programmes <strong>for</strong> <strong>smoking</strong> cessation.<br />
Cochrane Database of Systematic Reviews 2005;Issue 2. Art. No.: CD001007. DOI:<br />
10.1002/14651858.CD001007.pub2.<br />
19 Stead LF, Perera R, Lancaster T. Telephone counselling <strong>for</strong> <strong>smoking</strong> cessation. Cochrane<br />
Database of Systematic Reviews 2006;Issue 3. Art. No.: CD002850. DOI:<br />
10.1002/14651858.CD002850.pub2.<br />
20 Bock BC, Graham AL, Whiteley JA, Stoddard JL. A review of web-assisted tobacco<br />
interventions (WATIs). J Med Internet Res. 2008;10(5):e39.<br />
21 Cunningham JA. Access and interest: two important issues in considering the feasibility of<br />
web-assisted tobacco interventions. J Med Internet Res. 2008;10(5):e37.<br />
22 Stead LF, Bergson G, Lancaster T. Physician advice <strong>for</strong> <strong>smoking</strong> cessation. Cochrane<br />
Database of Systematic Reviews 2008;Issue 2. Art. No.: CD000165. DOI:<br />
10.1002/14651858.CD000165.pub3.<br />
23 Carr AB, Ebbert JO. Interventions <strong>for</strong> tobacco cessation in the dental setting. Cochrane<br />
Database of Systematic Reviews 2006;Issue 1. Art. No.: CD005084. DOI:<br />
10.1002/14651858.CD005084.pub2.<br />
24 Rice VH, Stead LF. Nursing interventions <strong>for</strong> <strong>smoking</strong> cessation. Cochrane Database of<br />
Systematic Reviews 2008;Issue 1. Art. No.: CD001188. DOI:<br />
10.1002/14651858.CD001188.pub3.<br />
25 Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions <strong>for</strong> <strong>smoking</strong><br />
cessation. Cochrane Database of Systematic Reviews 2004;Issue 1. Art. No.: CD003698.<br />
DOI: 10.1002/14651858.CD003698.pub2.<br />
26 Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy <strong>for</strong><br />
<strong>smoking</strong> cessation. Cochrane Database of Systematic Reviews 2008;Issue 1. Art. No.:<br />
CD000146. DOI: 10.1002/14651858.CD000146.pub3.<br />
27 Le Foll B, George TP. Treatment of tobacco dependence: integrating recent progress into<br />
practice. CMAJ 2007;177(11):1373-80.<br />
28 Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of<br />
Health and Human Services, Public Health Service, 2008.<br />
29 Cahill K, Moher M, Lancaster T. Workplace interventions <strong>for</strong> <strong>smoking</strong> cessation. Cochrane<br />
Database of Systematic Reviews 2008;Issue 4. Art. No.: CD003440. DOI:<br />
10.1002/14651858.CD003440.pub3.<br />
30 Centers <strong>for</strong> Disease Control and Prevention (CDC). <strong>Best</strong> Practices <strong>for</strong> Comprehensive<br />
Tobacco Control Programs—2007. Atlanta: U.S. Department of Health and Human Services,<br />
Centers <strong>for</strong> Disease Control and Prevention, National Center <strong>for</strong> Chronic Disease Prevention<br />
and Health Promotion, Office on Smoking and Health, 2007. Available online at:<br />
http://wwwtest.cdc.gov/tobacco/tobacco_control_programs/stateandcommunity/best_practice<br />
s/00_pdfs/2007/<strong>Best</strong>Practices_Complete.pdf.<br />
31 Institute of Medicine. Ending the Tobacco Problem: A Blueprint <strong>for</strong> the Nation. Washington<br />
DC: National Academy Press, 2007. Available online at:<br />
http://www.nap.edu/catalog/11795.html.<br />
55
32 Ontario Tobacco Research Unit. OTRU Update: Effects of Funding Cuts to Tobacco Control<br />
Programs. Toronto, ON: Ontario Tobacco Research Unit, 2008. Available online at:<br />
http://www.otru.org/pdf/updates/update_dec2008.pdf.<br />
33 McNeill A, Raw M, Whybrow J, Bailey P. A national strategy <strong>for</strong> <strong>smoking</strong> cessation treatment<br />
in England. Addiction 2005;100(Suppl. 2):1–11.<br />
34 S Thomas, D Fayter, K Misso, D Ogilvie, M Petticrew, A Sowden, M Whitehead, and G<br />
Worthy. Population tobacco control interventions and their effects on social inequalities in<br />
<strong>smoking</strong>: systematic review. Tob Control 2008;17:230-237.<br />
35 Murray RL, Bauld L, Hackshaw LE, McNeill A. Improving access to <strong>smoking</strong> cessation<br />
services <strong>for</strong> disadvantaged groups: a systematic review. J Public Health (Oxf) 2009. [Epub<br />
ahead of print]<br />
36 Use and misuse of tobacco among Aboriginal Peoples: update 2006. Canadian Paediatric<br />
Society (CPS) First Nations and Inuit Health Committee; Paediatrics & Child Health, 2006.<br />
Available online at: http://www.cps.ca/ENGLISH/statements/II/FNIH06-01.htm.<br />
37 Health Canada. Tobacco. Based on the 2004 Baseline Study among First Nations onreserve<br />
and Inuit in the North, Environics Research Group. Available online at: http://www.hcsc.gc.ca/fnih-spni/substan/tobac-tabac/index_e.html#facts.<br />
38 Assembly of First Nations. First Generation, Second Generation: An Enhanced First Nations<br />
Tobacco Strategy. Submission to the President of the Treasury Board, Secretariat, the<br />
Minister of Finance, and the Minister of Health, June 2007. p. 5.<br />
39 Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau<br />
N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT. Tobacco use and cessation in<br />
psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res<br />
2008;10(12):1691-715.<br />
40 Johnson JL, MacDonald S, Reist D, Bahadori K. Tobacco Reduction in the Context of Mental<br />
Illness and Addictions: A Review of the Evidence. Centre <strong>for</strong> Addiction Research of British<br />
Columbia, 2006. Available online at: http://www.phsa.ca/NR/rdonlyres/76D687CF-6596-<br />
46FE-AA9A-<br />
A536D61FB038/23509/TobaccoReductionintheContextofMentalIllnessandAddi.pdf.<br />
41 Kisely S, Campbell LA. Use of <strong>smoking</strong> cessation therapies in individuals with psychiatric<br />
illness: an update <strong>for</strong> prescribers. CNS Drugs. 2008;22(4):263-73.<br />
42 Ontario Tobacco Research Unit. OTS Progress and Implications, 2002-03. [Special Reports:<br />
Monitoring and Evaluation Series, 2002-2003;Vol. 9, No. 4]. Toronto, ON: Ontario Tobacco<br />
Research Unit, March 2004.<br />
43 Shea AK, Steiner M. Cigarette <strong>smoking</strong> during pregnancy. Nicotine Tob Res 2008;10(2):267-<br />
78.<br />
44 Greaves L, Cormier R, Devreis K, Bottorff J, Johnson JL, Kirkland S, Aboussafy D. Expecting<br />
to Quit: A <strong>Best</strong> Practices Review of Smoking Cessation Interventions <strong>for</strong> Pregnant and<br />
Postpartum Girls and Women. Prepared <strong>for</strong> Health Canada, April 2003. Available online at:<br />
http://www.hc-sc.gc.ca/hl-vs/pubs/tobac-tabac/expecting-grossesse/index-eng.php.<br />
45 Cahill K, Moher M, Lancaster T. Workplace interventions <strong>for</strong> <strong>smoking</strong> cessation. Cochrane<br />
Database of Systematic Reviews 2008;Issue 4. Art. No.: CD003440. DOI:<br />
10.1002/14651858.CD003440.pub3<br />
46 <strong>Hammond</strong> D. Young Adults and Smoking Behaviour: Beyond Youth Prevention. Tob Control 2005;<br />
14:181-185.<br />
56
47 Le Foll B, George TP. Treatment of tobacco dependence: integrating recent progress into<br />
practice. CMAJ 2007;177(11):1373-80.<br />
57